株探米国株
エドガーで原本を確認する

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

 the Securities Exchange Act of 1934

 

For the six months ended March 31, 2026

 

 Commission File Number: 001-38397

 

Farmmi, Inc.

(Registrant’s name)

 

Fl 1, Building No. 1,888 Tianning Street, Liandu District

Lishui, Zhejiang Province

People’s Republic of China 323000

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.:

 

Form 20-F ☒     Form 40-F ☐

 

 

 

 

Incorporation By Reference

 

This report on Form 6-K is hereby incorporated by reference into the Company’s registration statements on Form S-8 (File No. 333-224463; File No. 333-262696) and Form F-3 (File No. 333-280348) and into each prospectus outstanding under the foregoing registration statements, to the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

 

Explanatory Note:

 

The Registrant is filing this Report on Form 6-K to report its financial results for the six months ended March 31, 2026 and to discuss its recent corporate developments.

 

Attached as exhibits to this Report on Form 6-K are:

 

 

(1)

Unaudited Condensed Consolidated Financial Statements and related notes as Exhibit 99.1;

 

 

 

 

(2)

Management’s Discussion and Analysis of Financial Condition and Results of Operations as Exhibit 99.2;

 

 

 

 

(3)

Interactive Data File disclosure as Exhibit 101 in accordance with Rule 405 of Regulation S-T.

 

 

2

 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Statements in this current report with respect to the Company’s current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of the Company. Forward-looking statements include, but are not limited to, those statements using words such as “believe,” “expect,” “plans,” “strategy,” “prospects,” “forecast,” “estimate,” “project,” “anticipate,” “aim,” “intend,” “seek,” “may,” “might,” “could” or “should,” and words of similar meaning in connection with a discussion of future operations, financial performance, events or conditions. From time to time, oral or written forward-looking statements may also be included in other materials released to the public. These statements are based on management’s assumptions, judgments and beliefs in light of the information currently available to it. The Company cautions investors that a number of important risks and uncertainties could cause actual results to differ materially from those discussed in the forward-looking statements, including but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. Therefore, investors should not place undue reliance on such forward-looking statements. Actual results may differ significantly from those set forth in the forward-looking statements.

 

All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

 

 
3

 

 

Exhibit Index:

 

99.1 

 

Unaudited Condensed Consolidated Financial Statements and Related Notes for the Six Months Ended March 31, 2026 and 2025

99.2

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

101.INS

 

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

 

Cover Page Interactive Data File (formatted as inline XBRL).

 

 
4

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

FARMMI, INC.

 

 

 

 

Date: August 27, 2026

By:

/s/ Yefang Zhang

 

 

Name:

Yefang Zhang

 

 

Title:

Chief Executive Officer

 

 

 
5

 

 

EXHIBIT 99.1

 

FARMMI, INC.

 

UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

AS OF MARCH 31, 2026 AND SEPTEMBER 30, 2025 AND

FOR THE SIX MONTHS ENDED MARCH 31, 2026 AND 2025

 

 
F-1

 

 

FARMMI, INC.

 

TABLE OF CONTENTS

 

 

 

Page

 

Unaudited Condensed Consolidated Financial Statements

 

F-1

 

Condensed Consolidated Balance Sheets as of March 31, 2026 (Unaudited) and September 30, 2025

 

F-3

 

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the Six Months Ended March 31, 2026 and 2025

 

F-4

 

Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Six Months Ended March 31, 2026 and 2025

 

F-5

 

Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended March 31, 2026 and 2025

 

F-6

 

Notes to Unaudited Condensed Consolidated Financial Statements

 

F-7 

 

 

 
F-2

Table of Contents

 

Farmmi, Inc.

Condensed Consolidated Balance Sheets

 

 

 

 As of

 

 

 As of

 

 

 

 March 31,

 

 

 September 30,

 

 

 

 2026

 

 

 2025

 

Assets

 

(unaudited)

 

 

(audited)

 

Current Assets

 

 

 

 

 

 

Cash and restricted cash

 

$ 249,252

 

 

$ 804,098

 

Accounts receivable, net

 

 

20,236,439

 

 

 

13,095,167

 

Advances to suppliers, net

 

 

38,803,164

 

 

 

46,304,704

 

Note receivable, current portion

 

 

16,098,885

 

 

 

31,005,260

 

Inventories

 

 

-

 

 

 

1,544,462

 

Due from a related party

 

 

35,000

 

 

 

-

 

Other current assets, net

 

 

1,724,614

 

 

 

372,264

 

Total current assets

 

 

77,147,354

 

 

 

93,125,955

 

 

 

 

 

 

 

 

 

 

Non-Current Assets

 

 

 

 

 

 

 

 

Note receivable

 

 

19,676,415

 

 

 

28,620,240

 

Right-of-use assets, net

 

 

14,166,214

 

 

 

16,440,531

 

Long-term investments, net

 

 

-

 

 

 

6,932,404

 

Loan to a third party

 

 

2,598,033

 

 

 

-

 

Security deposits

 

 

881,631

 

 

 

1,877,272

 

Property and equipment, net

 

 

418,698

 

 

 

36,780

 

Total non-current assets

 

 

37,740,991

 

 

 

53,907,227

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$ 114,888,345

 

 

$ 147,033,182

 

 

 

 

 

 

 

 

 

 

Liabilities and Shareholders' Equity

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Promissory notes

 

 

2,519,134

 

 

 

2,519,134

 

Accounts payable

 

 

469,489

 

 

 

15,695

 

Due to related parties

 

 

3,892,013

 

 

 

293,919

 

Operating lease liabilities – current

 

 

3,690,692

 

 

 

5,030,911

 

Other current liabilities

 

 

3,097,960

 

 

 

2,096,671

 

Total current liabilities

 

 

13,669,288

 

 

 

9,956,330

 

 

 

 

 

 

 

 

 

 

Non-Current Liabilities

 

 

 

 

 

 

 

 

Long-term loans - non-current portion

 

 

-

 

 

 

1,809,780

 

Operating lease liabilities – non-current

 

 

10,475,522

 

 

 

11,409,620

 

Total non-current liabilities

 

 

10,475,522

 

 

 

13,219,400

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

 

24,144,810

 

 

 

23,175,730

 

 

 

 

 

 

 

 

 

 

Commitment and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' Equity

 

 

 

 

 

 

 

 

Class A Ordinary Shares, par value $0.00000001 and 4.5 billion shares authorized; 13,813,417 shares issued and outstanding as of March 31, 2026. Ordinary shares, $2.40 par value, 5 billion shares authorized, 5,481,874 shares issued and outstanding as of September 30, 2025.

 

 

-

 

 

 

13,156,498

 

Class B Ordinary Shares, par value $0.00000001, 0.5 billion shares authorized, 1,791 shares issued and outstanding as of March 31, 2026.

 

 

-

 

 

 

-

 

Subscription receivable

 

 

(18,000,002 )

 

 

-

 

Additional paid-in capital

 

 

194,583,302

 

 

 

161,426,802

 

Statutory reserve

 

 

687,173

 

 

 

687,173

 

Accumulated deficits

 

 

(76,949,665 )

 

 

(39,839,384 )

Accumulated other comprehensive loss

 

 

(8,836,701 )

 

 

(11,313,205 )

Total Farmmi, Inc.’s shareholders' equity

 

 

91,484,107

 

 

 

124,117,884

 

Noncontrolling interest

 

 

(740,572 )

 

 

(260,432 )

Total Shareholders' Equity

 

 

90,743,535

 

 

 

123,857,452

 

 

 

 

 

 

 

 

 

 

Total Liabilities and Shareholders' Equity

 

$ 114,888,345

 

 

$ 147,033,182

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
F-3

Table of Contents

 

Farmmi, Inc.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss

 

 

 

 For the Six Months Ended March 31,

 

 

 

 2026

 

 

 2025

 

 

 

 

 

 

 

 

Sales to third parties

 

$ 6,394,713

 

 

$ 16,144,172

 

Sales to related parties

 

 

-

 

 

 

137

 

Revenues

 

$ 6,394,713

 

 

$ 16,144,309

 

Cost of revenues

 

 

(7,484,087 )

 

 

(15,329,735 )

Gross (loss) profit

 

 

(1,089,374 )

 

 

814,574

 

Operating expenses

 

 

 

 

 

 

 

 

(Allowance) reversal of allowance for credit losses

 

 

(29,065,008 )

 

 

270,832

 

Long-term investment impairment loss

 

 

(7,044,116 )

 

 

-

 

Selling and distribution expenses

 

 

(311,446 )

 

 

(83,321 )

General and administrative expenses

 

 

(1,017,017 )

 

 

(1,670,829 )

Total operating expenses

 

 

(37,437,587 )

 

 

(1,483,318 )

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(38,526,961 )

 

 

(668,744 )

Other income, net

 

 

 

 

 

 

 

 

Interest income

 

 

23,380

 

 

 

3,622

 

Interest expense

 

 

(96,907 )

 

 

(231,704 )

Amortization of debt issuance costs

 

 

-

 

 

 

(177,014 )

Loss from equity method investment

 

 

-

 

 

 

(431,180 )

Other income, net

 

 

1,010,067

 

 

 

1,003,031

 

Gain on disposal of subsidiaries

 

 

-

 

 

 

250,331

 

Total other income, net

 

 

936,540

 

 

 

417,086

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

(37,590,421 )

 

 

(251,658 )

Income tax expenses

 

 

-

 

 

 

-

 

Net loss

 

 

(37,590,421 )

 

 

(251,658 )

Net loss attributable to non-controlling interest

 

 

480,140

 

 

 

207,642

 

Net loss attributable to Farmmi, Inc.

 

$ (37,110,281 )

 

$ (44,016 )

 

 

 

 

 

 

 

 

 

Comprehensive loss

 

 

 

 

 

 

 

 

Net loss

 

$ (37,590,421 )

 

$ (251,658 )

Foreign currency translation difference

 

 

2,476,504

 

 

 

(4,654,965 )

Total comprehensive loss

 

 

(35,113,917 )

 

 

(4,906,623 )

Comprehensive loss attributable to non-controlling interest

 

 

480,140

 

 

 

207,642

 

Comprehensive loss attributable to Farmmi, Inc.

 

$ (34,633,777 )

 

$ (4,698,981 )

 

 

 

 

 

 

 

 

 

Weighted average number of ordinary shares

 

 

 

 

 

 

 

 

Basic

 

 

11,401,729

 

 

 

1,077,719

 

Diluted

 

 

11,401,729

 

 

 

1,077,719

 

Loss per ordinary share

 

 

 

 

 

 

 

 

Basic

 

$ (3.25 )

 

$ (0.04 )

Diluted

 

$ (3.25 )

 

$ (0.04 )

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
F-4

Table of Contents

 

Farmmi, Inc.

Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity

For the Six Months Ended March 31, 2026 and 2025

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Other

 

 

Total

 

 

 

 

 

 

 

Ordinary shares

 

 

Paid in

 

 

Statutory

 

 

Retained

 

 

Comprehensive

 

 

Shareholders’

 

 

Noncontrolling

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Reserve

 

 

Earnings

 

 

Income (loss)

 

 

Equity

 

 

Interest

 

 

Equity

 

Balance as of September 30, 2024

 

 

889,906

 

 

$ 2,135,791

 

 

$ 161,571,245

 

 

$ 697,443

 

 

$ 13,248,995

 

 

$ (7,664,144 )

 

$ 169,989,330

 

 

$ 26,907

 

 

$ 170,016,237

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of ordinary shares for promissory notes redemption

 

 

100,182

 

 

 

240,437

 

 

 

97,572

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

338,009

 

 

 

-

 

 

 

338,009

 

Issuance of ordinary shares for warrants exercised

 

 

325,825

 

 

 

781,980

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

781,980

 

 

 

-

 

 

 

781,980

 

Reverse share-split adjustment

 

 

(706 )

 

 

(1,694 )

 

 

1,694

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Foreign currency translation loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,654,965 )

 

 

(4,654,965 )

 

 

-

 

 

 

(4,654,965 )

Disposal of subsidiaries

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(10,270 )

 

 

10,270

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net loss for the period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(44,016 )

 

 

-

 

 

 

(44,016 )

 

 

(207,642 )

 

 

(251,658 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of March 31, 2025

 

 

1,315,207

 

 

$ 3,156,514

 

 

$ 161,670,511

 

 

$ 687,173

 

 

$ 13,215,249

 

 

$ (12,319,109 )

 

$ 166,410,338

 

 

$ (180,735 )

 

$ 166,229,603

 

 

 

 

Class A

Ordinary Shares

 

 

Class B Ordinary Shares

 

 

Subscription

 

 

Additional

Paid in

 

 

Statutory

 

 

Retained

Earnings

(Accumulated

 

 

Accumulated

Other

Comprehensive

 

 

Total

Farmmi, Inc.’s

Shareholders’

 

 

Noncontrolling

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Receivable

 

 

Capital*

 

 

Reserve

 

 

Deficits)

 

 

loss

 

 

Equity

 

 

Interest

 

 

Equity

 

Balance as of September 30, 2025

 

 

5,481,874

 

 

$ 13,156,498

 

 

 

-

 

 

 

-

 

 

 

-

 

 

$ 161,426,802

 

 

$ 687,173

 

 

$ (39,839,384 )

 

$ (11,313,205 )

 

$ 124,117,884

 

 

$ (260,432 )

 

$ 123,857,452

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change of par value effect

 

 

-

 

 

 

(13,156,498 )

 

 

-

 

 

 

-

 

 

 

-

 

 

 

13,156,498

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of ordinary shares for warrants exercised

 

 

8,333,334

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(18,000,002 )

 

 

20,000,002

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,000,000

 

 

 

-

 

 

 

2,000,000

 

Reclassification of Class A shares to Class B Shares

 

 

(1,791 )

 

 

-

 

 

 

1,791

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Foreign currency translation gain

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,476,504

 

 

 

2,476,504

 

 

 

-

 

 

 

2,476,504

 

Net loss for the period

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(37,110,281 )

 

 

-

 

 

 

(37,110,281 )

 

 

(480,140 )

 

 

(37,590,421 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of March 31, 2026

 

 

13,813,417

 

 

 

-

 

 

 

1,791

 

 

 

-

 

 

$ (18,000,002 )

 

$ 194,583,302

 

 

$ 687,173

 

 

$ (76,949,665 )

 

$ (8,836,701 )

 

$ 91,484,107

 

 

$ (740,572 )

 

$ 90,743,535

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
F-5

Table of Contents

 

Farmmi, Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

 

 

 

 For the Six Months Ended March 31,

 

 

 

 2026

 

 

 2025

 

Cash flows from operating activities

 

 

 

 

 

 

Net loss

 

$ (37,590,421 )

 

$ (251,658 )

Adjustments to reconcile net loss to net cash (used in) provided by operating activities:

 

 

 

 

 

 

 

 

Changes in allowances - accounts receivable

 

 

(2,694,263 )

 

 

(262,764 )

Changes in allowances - advances to suppliers

 

 

31,692,011

 

 

 

-

 

Changes in allowances - other current assets

 

 

67,260

 

 

 

-

 

Long-term investment impairment loss

 

 

7,044,116

 

 

 

-

 

Depreciation

 

 

36,854

 

 

 

8,863

 

Amortization of operating lease right-of-use assets

 

 

2,275,501

 

 

 

1,785,055

 

Loss on short-term investment

 

 

-

 

 

 

431,180

 

Loss from disposal of subsidiaries

 

 

-

 

 

 

(250,331 )

Amortization of debt issuance costs

 

 

-

 

 

 

177,014

 

Interest expenses for promissory note redemption

 

 

89,631

 

 

 

184,176

 

Amortization of biological assets

 

 

-

 

 

 

105,645

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

(3,935,498 )

 

 

(8,418,637 )

Advances to suppliers, net

 

 

(22,845,676 )

 

 

16,848,563

 

Note receivable

 

 

23,850,200

 

 

 

-

 

Inventories, net

 

 

1,569,350

 

 

 

3,687,897

 

Other current assets

 

 

(1,412,292 )

 

 

550,819

 

Other non-current assets - security deposits

 

 

995,640

 

 

 

-

 

Accounts payable

 

 

453,724

 

 

 

964,027

 

Operating lease liabilities

 

 

(2,275,500 )

 

 

(1,788,947 )

Other current liabilities

 

 

1,399,058

 

 

 

799,065

 

Net cash (used in) provided by operating activities

 

 

(1,280,305 )

 

 

14,569,967

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

 

 

Purchase of property and equipment

 

 

(418,763 )

 

 

(16,666 )

Proceeds from disposal of subsidiaries, net of cash

 

 

-

 

 

 

(19,243 )

Purchase of long-term investments

 

 

-

 

 

 

(15,000,000 )

Loan to a third party

 

 

(3,842,464 )

 

 

-

 

Repayment of loan to a third party

 

 

1,244,431

 

 

 

-

 

Net cash used in investing activities

 

 

(3,016,796 )

 

 

(15,035,909 )

 

 

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

 

Repayment of promissory notes

 

 

-

 

 

 

(1,000,000 )

Borrowings from a third-party loan

 

 

-

 

 

 

1,679,900

 

Repayment of a third-party loan

 

 

(1,809,780 )

 

 

(471,472 )

Proceeds from issuance of ordinary shares for warrants exercised

 

 

2,000,000

 

 

 

781,980

 

Due from a related party

 

 

(35,000 )

 

 

(115,200 )

Proceeds from advances from related parties

 

 

3,586,008

 

 

 

-

 

Net cash provided by financing activities

 

 

3,741,228

 

 

 

875,208

 

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash

 

 

1,027

 

 

 

(5,452 )

Net (decrease) increase in cash

 

 

(554,846 )

 

 

403,814

 

Cash and restricted cash, beginning of period

 

 

804,098

 

 

 

486,522

 

Cash and restricted cash, end of period

 

$ 249,252

 

 

$ 890,336

 

 

 

 

 

 

 

 

 

 

Representing:

 

 

 

 

 

 

 

 

Cash, end of period

 

$ 248,578

 

 

$ 890,336

 

Restricted cash, end of period

 

 

674

 

 

 

-

 

Total cash and restricted cash, end of period

 

$ 249,252

 

 

$ 890,336

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure information:

 

 

 

 

 

 

 

 

Income taxes paid

 

 

-

 

 

 

-

 

Interest paid

 

$ 73,156

 

 

$ 126,226

 

 

 

 

 

 

 

 

 

 

Non-cash financing activities

 

 

 

 

 

 

 

 

Acquisition of long-term investment through issuance of note receivable

 

 

-

 

 

$ 35,000,000

 

Issuance of ordinary shares for promissory notes redemption

 

 

-

 

 

$ 338,009

 

Accrued interest in promissory notes

 

 

-

 

 

$ 112,814

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 
F-6

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1 — Organization and nature of business

 

Farmmi, Inc. (“FAMI” or the “Company”) is a holding company incorporated under the laws of the Cayman Islands on July 28, 2015. FAMI owns 100% equity interest of Farmmi International Limited (“Farmmi International”), a Hong Kong company, which in turn owns 100% equity interest in Zhejiang Suyuan Agricultural Technology Co., Ltd (“Zhejiang Suyuan Agricultural”), Farmmi (Hangzhou) Enterprise Management Co., Ltd. (“Farmmi Enterprise”) and Farmmi (Hangzhou) Health Development Co., Ltd (“Farmmi Heath Development”), and these subsidiaries were established under the laws of the People’s Republic of China (“PRC” or “China”). Also, FAMI owns 100% equity interest in Farmmi USA Inc (“Farmmi USA”), which was established under the laws of the State of California.

 

Farmmi Enterprise owns 100% equity interest in Zhejiang Farmmi Ecological Agriculture Technology Co., Ltd (“Farmmi Eco Agri”). Farmmi Eco Agri owns 100% equity interests in Lishui Farmmi E-Commerce Co., Ltd. (“Farmmi E-Commerce”), Zhejiang Farmmi Food Co., Ltd. (“Farmmi Food”), Zhejiang Farmmi Agricultural Supply Chain Co., Ltd. (“Farmmi Supply Chain”), Ningbo Farmmi Baitong Trade Co., Ltd (“Ningbo Farmmi Trade”) and Zhejiang Farmmi Biotechnology Co., Ltd. (“Farmmi Biotech”).

 

Farmmi Supply Chain owns 100% equity interest in Jiangxi Xiangbo Agriculture and Forestry Development Co. Ltd (“Jiangxi Xiangbo”) and Guoning Zhonghao (Ningbo) Trading Co., Ltd. (“Guoning Zhonghao”). Jiangxi Xiangbo owns 100% equity interest in Yudu County Yada Forestry Co., Ltd. (“Yudu Yada”).

 

Farmmi Health Development owns 100% equity interest in Zhejiang Farmmi Healthcare Technology Co., Ltd (“Farmmi Healthcare”). Farmmi Healthcare and Farmmi Health Development own 95% and 5% of the equity interests in Zhejiang Yitang Medical Service Co., Ltd. (“Yitang Mediservice”), respectively. Yitang Mediservice owns 100% interest in Zhejiang Yiting Medical Technology Co., Ltd. (“Yiting Meditech”).

 

On July 13, 2022, Farmmi Canada Inc. (Farmmi Canada) was established under the laws of Canada. Farmmi Inc. owns 100% of the equity interest in Farmmi Canada. Farmmi Canada was dissolved on December 31, 2024.

 

On July 23, 2024, SuppChains Group Inc (“SuppChains”) was established under the laws of the State of California. Farmmi USA owns 75% equity of SuppChains.

 

On October 31, 2024, Suppchains Transport Inc (“Suppchains Transport”) was established under the laws of the State of California. SuppChains owns 100% equity of SuppChains Transport.

 

On November 4, 2024, Zhejiang Famimi Biotechnology Co., Ltd (“Famimi Biotech”) was established under the laws of PRC, where Zhejiang Suyuan Agricultural owns 95% and Farmmi E-Commerce owns 5% of Famimi Biotech, respectively.

 

In March 2025, the Company internally reorganized its subsidiaries. After reorganization, Yitang Mediservice owns 100% interest in Jiangxi Xiangbo, Guoning Zhonghao and Ningbo Farmmi Trade.

 

On March 31, 2025, an agreement was signed to divest 100% interest in Farmmi Food and Farmmi Supply Chain to a third party for a total cash consideration of RMB20,000 ($2,754).

 

In June 2025, agreements were signed to divest 100% interest in Farmmi Biotech, Guoning Zhonghao and Ningbo Farmmi Trade to third parties for a total cash consideration of RMB10,000 ($1,405), RMB10,000 ($1,405), and RMB5,000 ($702), respectively.

 

On August 6, 2025, Suppchains Oak Inc (“Suppchains Oak”) was established under the laws of the State of New Jersey, the United States of America. Suppchains Transport owns 100% equity of Suppchains Oak.

 

On January 13, 2026, Bluesage Marketing Inc (“Bluesage”) was established under the laws of the State of California, the United States of America. Farmmi USA owns 100% equity of Bluesage.

 

F-7

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1 — Organization and nature of business (continued)

 

As of March 31, 2026, details of the subsidiaries of FAMI are set out below:

 

Name of Entity

Date of Incorporation

Place of Incorporation

% of Ownership

Principal activities

FAMI

July 28, 2015

Cayman

Parent

Holding company

Farmmi International

August 20, 2015

Hong Kong

100%

Holding company

Farmmi Enterprise

May 23, 2016

Zhejiang, China

100%

Holding company

Farmmi Health Development

September 17, 2021

Zhejiang, China

100%

Holding company

Zhejiang Suyuan Agricultural

July 25, 2022

Zhejiang, China

100%

Holding company

Farmmi Eco Agri

May 27, 2022

Zhejiang, China

100%

Agriculture products

Farmmi E-Commerce

March 22, 2019

Zhejiang, China

100%

Agriculture products

Farmmi Healthcare

September 18, 2021

Zhejiang, China

100%

Medical health

Yitang Mediservice

September 7, 2021

Zhejiang, China

100%

Medical services

Yiting Meditech

September 17, 2021

Zhejiang, China

100%

Medical technology

Jiangxi Xiangbo

June 18, 2021

Jiangxi, China

100%

Holding company

Yudu Yada

November 10, 2010

Jiangxi, China

100%

Forestry development

Farmmi USA

April 20, 2023

California, USA

100%

Agriculture products

SuppChains

July 23, 2024

California, USA

75%

Trading

Suppchains Transport

October 31, 2024

California, USA

100%

Trading

Suppchains Oak

August 6, 2025

New Jersey, USA

100%

Trading

Bluesage

January 13, 2026

California, USA

100%

Trading

 

 
F-8

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Liquidity

 

In assessing the Company’s liquidity and substantial doubt about its ability to continue as a going concern, the Company monitors and analyzes cash on-hand and operating expenditure commitments. The Company’s liquidity needs are to meet working capital requirements and operating expense obligations. To date, the Company financed its operations primarily through cash generated by operating activities, issuance of promissory notes, and issuance of ordinary shares.

 

The accompanying unaudited condensed consolidated financial statements do not include any adjustments or classifications that may result from the possible inability of the Company to continue as a going concern. The accompanying unaudited condensed financial statements have been prepared on a basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company recorded net loss of approximately $37.6 million for the six months ended March 31, 2026. The above matters raise substantial doubt about the Company’s ability to continue as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. As of March 31, 2026, the Company had cash balance of approximately $0.2 million.

 

Management plans to address the conditions that raise substantial doubt about the Company’s ability to continue as a going concern through (i) obtaining additional equity or debt financing and (ii) reducing cash used in operating activities. The Company may, however, need additional capital in the future to fund its further expansion. If the Company determines that its cash requirements exceed the amount of cash it has on hand at the time, the Company may seek to issue equity or debt securities or obtain credit facilities. The issuance and sale of additional equity would result in further dilution to shareholders of the Company.

 

As a result, the Company prepared the unaudited condensed consolidated financial statements assuming the Company will continue as a going concern. However, there is no assurance that the measures above can be achieved as planned. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Note 2 — Summary of significant accounting policies

 

Basis of presentation and principles of consolidation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and have been consistently applied. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. These financial statements should be read in conjunction with the audited financial statements and notes thereto for the fiscal years ended September 30, 2025 and 2024. Operating results for the six months ended March 31, 2026 are not necessarily indicative of the results that may be expected for the year ending September 30, 2026.

 

The unaudited condensed consolidated financial statements of the Company reflect the principal activities of the Company’s main operating subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation.

 

 
F-9

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of significant accounting policies (continued)

 

Use of estimates

 

In preparing the unaudited condensed consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates and assumptions include allowance for credit losses for accounts receivable, advances to suppliers, note receivable, and security deposits, the valuation of inventories, the impairment of long-term investments and right-of-use assets, the useful lives of property and equipment, and the valuation of deferred tax assets. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

 

Cash

 

Cash includes currency on hand and deposits held by banks that can be added or withdrawn without limitation. Cash balances are in bank accounts in the People’s Republic of China and the United States of America. Cash maintained in banks within the PRC of less than RMB 0.5 million (equivalent to $72,485) per bank are covered by “deposit insurance regulation” promulgated by the State Council of the People’s Republic of China. Cash maintained with U.S. financial institutions of less than $250,000 are covered by the Federal Deposit Insurance Corporation or other programs.

 

Accounts and note receivable, net

 

Accounts and note receivable are presented with net of an allowance for credit losses. The Company maintains an allowance for credit losses for estimated losses. The Company reviews its accounts receivable on a periodic basis and makes general and specific allowances when there is doubt as to the collectability of individual balances. In evaluating the collectability of individual receivable balances, the Company considers many factors, including the age of the balance, customer’s payment history and current credit-worthiness, and current economic trends. Accounts are written off after efforts at collection prove unsuccessful.

 

Advances to suppliers, net

 

Advances to suppliers represent prepayments made to ensure continuous high-quality supplies and favorable purchase prices for premium quality. These advances are directly related to the purchases of raw materials used to fulfill sales orders. The Company is required from time to time to make cash advances when placing its purchase orders. These advances are settled upon suppliers delivering raw materials to the Company when the transfer of ownership occurs. The Company reviews its advances to suppliers on a periodic basis and makes general and specific allowances when there is doubt as to the ability of a supplier to provide supplies to the Company or refund an advance.

 

 
F-10

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of significant accounting policies (continued)

 

Inventories, net

 

The Company values its inventories at the lower of cost, determined on a weighted average basis, or net realizable value. The Company reviews its inventories periodically to determine if any reserves are necessary for potential obsolescence or if the carrying value exceeds net realizable value.

 

Long-term investments

 

The Company’s long-term investments consist of equity method investments.

 

Investments in entities over which the Company has the ability to exercise significant influence, but does not have a controlling financial interest, are accounted for using the equity method of accounting. Under the equity method, the Company initially records its investment at cost and subsequently recognizes its proportionate share of the investee’s net income or loss. The Company evaluates its equity method investments for impairment when events or circumstances indicate that a decrease in value below the carrying amount is other than temporary. If such a decline is determined to be other than temporary, an impairment loss is recognized to write the investment down to its fair value.

 

As of March 31, 2026 and September 30, 2025, the Company evaluated its investments, taking into consideration, including, but not limited to, the duration, degree and causes of the decline in financial results, its intent and ability to hold the investment and the invested companies’ financial performance and near-term prospects. During the six months ended March 31, 2026, the Company recognized an impairment loss of approximately $7.0 million related to its long-term investment based on management's assessment of the recoverability of the investment.

 

The Company’s long-term investments are equity method investments. Investee companies over which the Company has the ability to exercise significant influence but does not have a controlling interest through investment in ordinary shares or in-substance ordinary shares are accounted for using the equity method. Significant influence is generally considered to exist when the Company has an ownership interest in the voting stock of the investee between 20% and 50%, and other factors, such as representation on the investee’s board of directors, voting rights and the impact of commercial arrangements, are also considered in determining whether the equity method of accounting is appropriate.

 

Under the equity method, the Company initially records its investment at cost and subsequently recognizes the Company’s proportionate share of each equity investee’s net income or loss after the date of investment into net loss and accordingly adjusts the carrying amount of the investment. The Company reviews its equity method investments for impairment whenever an event or circumstance indicates that any other-than-temporary impairment has occurred. The Company considers available quantitative and qualitative evidence in evaluating potential impairment of its equity method investment.

 

An impairment charge is recorded when the carrying amount of the investment exceeds its fair value and this condition is determined to be other-than-temporary. As of March 31, 2026 and September 30, 2025, the cumulative impairment for long-term investments was approximately $7.4 million and $0.2 million, respectively.

 

 
F-11

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of significant accounting policies (continued)

 

Property and equipment, net

 

Property and equipment are stated at cost less accumulated depreciation. The cost of an asset comprises its purchase price and any directly attributable costs of bringing the asset to its present working condition and location for its intended use.

 

Depreciation is computed on a straight-line basis over the estimated useful lives of the related assets. The estimated useful lives for significant property and equipment are as follows:

 

Machinery and equipment

 

510 years

 

Transportation equipment

 

4 years

 

Office equipment

 

35 years

 

 

Expenditures for maintenance and repairs, which do not materially extend the useful lives of the assets, are charged to expense as incurred. Expenditures for major renewals and betterments which substantially extend the useful life of assets are capitalized.

 

Impairment of long-lived assets

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

 
F-12

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of significant accounting policies (continued)

 

Revenue recognition

 

The Company follows ASU 2014-09 Revenue from Contracts with Customers (“ASC Topic 606”). In accordance with ASC 606, to determine revenue recognition for contracts with customers, the Company performs the following five steps: (i) identify the contract(s) with the customer, (ii) identify the performance obligation(s) in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligation(s) in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

 

The Company’s principal businesses are (i) processing, distributing, and trading dried Shiitake mushrooms, Mu Er (also known as Auricularia heimuer or black ear fungus), other edible fungi, and other agricultural products (e.g., tapioca, corn, cotton, and cornstarch), and (ii) providing warehousing and logistics services (including operation services, outbound delivery services, storage services, and special work order services).

 

Revenue from trading and sales of agricultural products (including dried Shiitake mushrooms, Mu Er, and other edible fungi), operation services, and special work order services

 

The Company enters into contracts with customers as a principal and primary obligator and has the discretion to determine prices and vendors. Each contract contains one performance obligation, which is transferring the product(s) or service(s) to the Company’s customer in exchange for consideration. The terms of pricing and payment stipulated in the contract are fixed. Usually, the Company requires certain customers to pay in advance or offers a credit term within six months for business customers with good credit worthiness. The Company recognizes revenue at the point in time when the control of the product(s) or service(s) has been transferred to the customer. The transfer of control is considered complete when the product(s) or service(s) have been accepted and received by the customer.

 

Revenue from outbound delivery and storage services

 

The Company enters into contracts with customers as a principal and primary obligator and has the discretion to determine prices and vendors. Outbound delivery and storage services are considered distinct services that are recognized over time when the performance obligations have been provided. Outbound delivery services are performed by the Company for the customers generally from shipment pickup to delivery. Storage services are recognized over the duration of the storage contractual period.

 

Contract balances and remaining performance obligations

 

The Company’s contract liabilities primarily include advances from customers. As of March 31, 2026 and September 30, 2025, the contract liabilities are $484,862 and $602,721, respectively, and included in other current liabilities on the consolidated balance sheets. For the six months ended March 31, 2026 and 2025, there was no revenue recognized from performance obligations related to prior periods.

 

Cost of revenues

 

Cost of revenues includes cost of raw materials purchased, inbound freight cost, cost of direct labor, depreciation expense, and other overhead.

 

 
F-13

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of significant accounting policies (continued)

 

Earnings (loss) per share

 

The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, Earnings per Share (“ASC 260”). ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is measured as net income (loss) divided by the weighted average ordinary shares outstanding for the period. Diluted EPS is similar to basic EPS but presents the dilutive effect on a per share basis of potential ordinary shares (e.g., convertible securities, and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

 

The components of basic and diluted EPS were as follows:

 

Six months ended March 31,

 

2026

 

 

2025

 

Net loss available for ordinary shareholders (A)

 

$ (37,110,281 )

 

$ (44,016 )

 

 

 

 

 

 

 

 

 

Weighted average outstanding ordinary shares (B)

 

 

 

 

 

 

 

 

- basic

 

 

11,401,729

 

 

 

1,077,719

 

- diluted

 

 

11,401,729

 

 

 

1,077,719

 

 

 

 

 

 

 

 

 

 

Loss per ordinary share - basic (A/B)

 

$ (3.25 )

 

$ (0.04 )

 

 

 

 

 

 

 

 

 

Loss per ordinary share - diluted (A/B)

 

$ (3.25 )

 

$ (0.04 )

 

Securities that could potentially dilute earnings per share in the future that were not included in the computation of diluted earnings per share for the six months ended March 31, 2026, and 2025 are as follows: 

 

 

 

As of

 

 

As of

 

 

 

March 31

 

 

March 31

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(unaudited)

 

Warrants to purchase ordinary shares

 

 

747,040

 

 

 

747,040

 

 

 
F-14

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of significant accounting policies (continued)

 

Fair value of financial instruments

 

The FASB ASC Topic 820, Fair Value Measurements, defines fair value, establishes a three-level valuation hierarchy for fair value measurements, and enhances disclosure requirements.

 

The three levels are defined as follows:

 

Level 1 — Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

 

Level 2 — Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted market prices for identical or similar assets in markets that are not active, inputs other than quoted prices that are observable and inputs derived from or corroborated by observable market data.

 

Level 3 — Inputs to the valuation methodology are unobservable.

 

Unless otherwise disclosed, the carrying amounts of the Company’s financial instruments, including cash and restricted cash, accounts receivable, note receivable, loan to a third party, accounts payable, amounts due to and from related parties, promissory notes and long-term loans, approximate their fair values due to their short-term nature or because the applicable interest rates approximate market rates.

 

 
F-15

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of significant accounting policies (continued)

 

Concentrations of credit risk

 

Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash, accounts receivable, note receivable, and advances to suppliers. As of March 31, 2026 and September 30, 2025, $35,356 and $30,502, respectively, of the Company’s cash is maintained in banks within the People’s Republic of China, of which deposits of RMB0.5 million (equivalent to $72,485) per bank are covered by “deposit insurance regulation” promulgated by the State Council of the People’s Republic of China. As of March 31, 2026 and September 30, 2025, cash balances of $213,896 and $772,975, respectively, were maintained at U.S. financial institutions and each U.S. account was insured by the Federal Deposit Insurance Corporation or other programs subject to $250,000 limitations. The Company has not experienced any losses in such accounts. A significant portion of the Company’s sales are credit sales primarily to customers whose ability to pay is dependent upon the industry economics prevailing in these areas. The Company also makes cash advances to certain suppliers to ensure the stable supply of key raw materials. The Company performs ongoing credit evaluations of its customers and key suppliers to help further reduce credit risk.

 

Comprehensive income (loss)

 

Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains, and losses that under U.S. GAAP are recorded as an element of stockholders’ equity but are excluded from net income (loss). Other comprehensive income (loss) consists of foreign currency translation adjustment from the Company not using the U.S. dollar as its functional currency.

 

Leases

 

The Company accounts for leases following ASC 842, Leases (“Topic 842”).

 

The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current portion of obligations under operating leases, and obligations under operating leases, non-current on the Company’s consolidated balance sheets.

 

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and includes initial direct costs incurred. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expenses for minimum lease payments are recognized on a straight-line basis over the lease term.

 

The Company has elected the practical expedient to account for lease and associated non-lease components as a single lease component.

 

The Company evaluates the impairment of its right-of-use assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of finance and operating lease liabilities in any tested asset group and include the associated lease payments in the undiscounted future pre-tax cash flows. As of March 31, 2026 and September 30, 2025, the Company did not have any impairment loss for its operating lease right-of-use assets.

 

 
F-16

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of significant accounting policies (continued)

 

Foreign currency translation

 

The Company’s financial information is presented in U.S. dollars (“USD”). The functional currency of the Company is the Chinese Yuan Renminbi (“RMB”), the currency of the PRC. Any transactions which are denominated in currencies other than RMB are translated into RMB at the exchange rate quoted by the People’s Bank of China prevailing at the dates of the transactions, and exchange gains and losses are included in the statements of operations as foreign currency transaction gain or loss. The unaudited condensed consolidated financial statements of the Company have been translated into U.S. dollars in accordance with ASC 830, Foreign Currency Matters. The financial information is first prepared in RMB and then translated into U.S. dollars at period-end exchange rates for assets and liabilities and average exchange rates for revenue and expenses. Capital accounts are translated at their historical exchange rates when the capital transactions occur. The effects of foreign currency translation adjustments are included as a component of accumulated other comprehensive income (loss) in stockholders’ equity. Cash flows from the Company’s operations are calculated based upon the local currencies using the average translation rate. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.

 

The exchange rates in effect as of March 31, 2026 and September 30, 2025 were US$1 for RMB6.8980 and RMB7.1190, respectively. The average exchange rates for the six months ended March 31, 2026 and 2025 were US$1 for RMB7.0061 and RMB7.2308, respectively.

 

Shipping and handling expenses

 

All shipping and handling costs are expensed as incurred and included in selling expenses. Total shipping and handling expenses were $1,405 and $47,352 for the six months ended March 31, 2026 and 2025, respectively, which included selling and distribution expenses in the accompanying unaudited condensed statements of operations.

 

 
F-17

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of significant accounting policies (continued)

 

Value added tax

 

The Company is generally subject to the value added tax (“VAT”) for selling merchandise. Before May 1, 2018, the applicable VAT rate was 13% or 17% (depending on the type of goods involved) for products sold in the PRC. After May 1, 2018, the Company is subject to a tax rate of 12% or 16%, and after April 1, 2019, the tax rate was further reduced to 9% or 13% based on the new Chinese tax law. Pursuant to approval issued by the State Administration of Taxation, Farmmi Eco Agri’s major operation can be classified as agriculture products and its revenue is exempt from VAT. The amount of VAT liability is determined by applying the applicable tax rate to the invoiced amount of goods sold (output VAT) less VAT paid on purchases made with the relevant supporting invoices (input VAT). Under the commercial practice of the PRC, the Company pays VAT based on tax invoices issued. The tax invoices may be issued subsequent to the date on which revenue is recognized, and there may be a considerable delay between the date on which the revenue is recognized and the date on which the tax invoice is issued. In the event the PRC tax authorities dispute the date on which revenue is recognized for tax purposes, the PRC tax authorities have the right to assess a penalty based on the amount of taxes which is determined to be late or deficient, with any penalty being expensed in the period when a determination is made by the tax authorities that a penalty is due. During the reporting periods, the Company had no dispute with PRC tax authorities, and there was no tax penalty incurred.

 

Income taxes

 

The Company’s subsidiaries in PRC are subject to the income tax laws of the PRC, and subsidiaries in the United States of America are subject to income tax laws of the United States of America. The Company accounts for income taxes in accordance with ASC 740, Income Taxes. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits or not be deductible in the future.

 

ASC 740-10-25 prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken (or expected to be taken) in a tax return. It also provides guidance on the recognition of income tax assets and liabilities, classification accounting for interest and penalties associated with tax positions, years open for tax examination, accounting for income taxes in interim periods, and income tax disclosures. There were no material uncertain tax positions as of March 31, 2026 and September 30, 2025. As of March 31, 2026, the tax years ended December 31, 2015 through December 31, 2025 for the Company’s subsidiaries remain open for statutory examination by PRC and USA tax authorities.

 

Statement of Cash Flows

 

In accordance with ASC 230, Statement of Cash Flows, cash flows from the Company’s operations are formulated based upon the local currencies. As a result, amounts related to assets and liabilities reported on the statements of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheets.

 

 
F-18

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of significant accounting policies (continued)

 

Risks and uncertainties

 

The operations of the Company are located in the PRC and U.S. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, in addition to the general state of the PRC and U.S. economies. The Company’s results may be adversely affected by changes in the political and social conditions in the PRC and U.S. and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.

 

The Company’s sales, purchases, and expense transactions are denominated in RMB, and a substantial part of the Company’s assets and liabilities are also denominated in RMB. RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions at exchange rates set by the People’s Bank of China, the central bank of China. Remittances in currencies other than RMB may require certain supporting documentation in order to affect the remittance.

 

The Company’s operating entities do not carry any business interruption insurance, product liability insurance, or any other insurance policy except for a limited property insurance policy. As a result, the Company may incur uninsured losses, increasing the possibility that investors would lose their entire investment in the Company.

 

The Company’s business, financial condition, and results of operations may also be negatively impacted by risks related to natural disasters, extreme weather conditions, health epidemics, and other catastrophic incidents, which could significantly disrupt the Company’s operations.

 

 
F-19

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 2 — Summary of significant accounting policies (continued)

 

Recent accounting pronouncements

 

The Company considers the applicability and impact of all ASUs. Management periodically reviews new accounting standards that are issued.

 

In November 2024, the FASB issued ASU 2024-03, Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires that public business entities disclose additional information about specific expense categories in the notes to financial statements at interim and annual reporting periods. This ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027 with early adoption permitted. This ASU may be applied either on a prospective or retrospective basis. We are currently evaluating the impact of this standard on our disclosures.

 

In January 2025, the FASB issued ASU 2025-01, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40), which clarifies that all public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption of Update 2024-03 is permitted.

 

In May 2025, the FASB issued ASU 2025-04, Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a customer, which clarifies the accounting for share-based consideration payable to customers. The amendments are effective for the Company beginning October 1, 2027, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In September 2025, the FASB issued ASU 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software,” which modernizes the accounting for internal-use software costs by removing the prescriptive project-stage guidance and establishing updated criteria for determining when software development costs should be capitalized. The amendments also update certain disclosure requirements and supersede the existing website development cost guidance. The amendments are effective for the Company beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In September 2025, the FASB issued ASU 2025-07, “Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606): Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract.” The amendments refine the scope of derivative accounting for certain contracts and clarify the accounting for share-based noncash consideration received from customers under Topic 606. The amendments are effective for annual reporting periods beginning after December 15, 2026, including interim periods within those annual reporting periods, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In November 2025, the FASB issued ASU 2025-08, “Financial Instruments—Credit Losses (Topic 326): Purchased Loans,” which expands the population of acquired loans subject to the gross-up approach under Topic 326. The amendments are effective for annual reporting periods beginning after December 15, 2026, including interim periods within those annual reporting periods, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In November 2025, the FASB issued ASU 2025-09, “Derivatives and Hedging (Topic 815): Hedge Accounting Improvements,” which expands and clarifies the application of hedge accounting for certain cash flow hedges, nonfinancial components, net written options, and certain foreign currency and interest rate hedging relationships. The amendments are effective for public business entities for annual reporting periods beginning after December 15, 2026, including interim periods within those annual reporting periods, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In December 2025, the FASB issued ASU 2025-10, “Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities,” which establishes recognition, measurement, presentation, and disclosure requirements for government grants received by business entities, including grants related to assets and income. The amendments are effective for annual reporting periods beginning after December 15, 2028, including interim reporting periods within those annual reporting periods, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In December 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270): Narrow-Scope Improvements,” which clarifies interim disclosure requirements, the applicability of Topic 270, and the form and content of interim financial statements, and establishes a disclosure principle for material events occurring since the end of the most recent annual reporting period. The amendments are effective for public business entities for interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its interim financial reporting and disclosures.

 

In December 2025, the FASB issued ASU 2025-12, “Codification Improvements,” which makes various amendments to the Accounting Standards Codification to clarify guidance, correct unintended applications, and improve consistency. The amendments are effective for annual reporting periods beginning after December 15, 2026, including interim periods within those annual reporting periods, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In April 2026, the FASB issued ASU 2026-01, “Equity (Topic 505): Initial Measurement of Paid-in-Kind Dividends on Equity-Classified Preferred Stock,” which provides guidance for the initial measurement of paid-in-kind dividends on equity-classified preferred stock. The amendments are effective for annual reporting periods beginning after December 15, 2026, including interim periods within those annual reporting periods, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

In May 2026, the FASB issued ASU 2026-02, “Environmental Credits and Environmental Credit Obligations (Topic 818),” which establishes accounting and disclosure requirements for environmental credits and obligations arising from environmental credit regulatory compliance programs. For public business entities, the amendments are effective for annual reporting periods beginning after December 15, 2027, including interim periods within those annual reporting periods, with early adoption permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

 

The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial position, statements of operations, cash flows, and disclosures.

 

 
F-20

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 3 — Accounts receivable, net

 

Accounts receivable consisted of the following:

 

 

 

As of

 

 

As of

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(audited)

 

Accounts receivable

 

$ 52,783,450

 

 

$ 47,284,561

 

Less: allowance for credit losses

 

 

(32,547,011 )

 

 

(34,189,394 )

Accounts receivable, net

 

$ 20,236,439

 

 

$ 13,095,167

 

 

Allowance for credit losses of approximately $32.5 million and approximately $34.2 million was made for certain accounts receivable as of March 31, 2026 and September 30, 2025, respectively. The Company’s accounts receivable primarily include balances due from customers when the Company’s products are sold and delivered to customers.

 

The movement of allowance for credit losses was as follows:

 

 

 

 For the Six

 

 

 For the

 

 

 

 Months Ended

 

 

 Year Ended

 

 

 

 March 31,

 

 

 September 30,

 

 

 

 2026

 

 

 2025

 

 

 

 (unaudited)

 

 

 (audited)

 

Balance as of beginning of period

 

$ 34,189,394

 

 

$ 302,914

 

(Reversal of) allowance for credit losses

 

 

(2,775,018 )

 

 

33,451,447

 

Translation adjustments

 

 

1,132,635

 

 

 

435,033

 

Balance as of end of period

 

$ 32,547,011

 

 

$ 34,189,394

 

 

Note 4 — Advances to suppliers, net

 

Advances to suppliers consisted of the following:

 

 

 

As of

 

 

As of

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

Advances to suppliers:

 

(unaudited)

 

 

(audited)

 

Qingyuan Nongbang Mushroom Industry Co., Ltd

 

$ 35,772,877

 

 

$ 16,848,007

 

Jingning Liannong Trading Co., Ltd

 

 

35,212,951

 

 

 

16,092,973

 

Lishui Zhelin Trading Co., Ltd

 

 

10,450,058

 

 

 

23,470,221

 

Others

 

 

5,999

 

 

 

19,153

 

Sub-total

 

$ 81,441,885

 

 

$ 56,430,354

 

Less: allowance for credit losses

 

 

(42,638,721 )

 

 

(10,125,650 )

Advances to suppliers, net

 

$ 38,803,164

 

 

$ 46,304,704

 

 

 
F-21

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

The movement of allowance for impairment loss was as follows:

 

 

 

For the Six

 

 

For the

 

 

 

Months Ended

 

 

Year Ended

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(audited)

 

Balance as of beginning of period

 

$ 10,125,650

 

 

 

-

 

Additions

 

 

31,692,011

 

 

 

9,994,385

 

Translation adjustments

 

 

821,060

 

 

 

131,265

 

Balance as of end of period

 

$ 42,638,721

 

 

$ 10,125,650

 

 

On April 1, 2016, the Company entered into two separate framework supply agreements (“Framework Agreements”) with two co-operatives, Jingning Liannong Trading Co., Ltd (“JLT”) and Qingyuan Nongbang Mushroom Industry Co., Ltd (“QNMI”). These two Framework Agreements were renewed for another three years in April 2019 upon expiration and were further renewed for another three years in June 2021. Jingning County and Qingyuan County, where JLT and QNMI are located, produce premium Shiitake and Mu Er.

 

On April 1, 2020, the Company signed a framework cooperation agreement with Lishui Zhelin Trading Co., Ltd. (“Zhelin Trade”), which is valid for four years. Zhelin Trade is located in the agricultural product distribution center in Liandu District - Southwest Zhejiang Agricultural Trade City, which has convenient logistics and timely agricultural product information. Therefore, the cooperation agreement stipulates that Zhelin Trade will process and deliver edible mushroom products on behalf of Zhelin Trade, and the Company is required to make advance payment to ensure the timeliness of goods supply and delivery.

 

Many competitors of the Company and other large buyers go to family farms and co-operatives to source their supplies. Family farms and co-operatives traditionally request advance payments to secure supplies. By making advance payments to these suppliers, the Company is also able to lock in a more favorable price for premium quality than would be available in the open market.

 

The Framework Agreements only provide general guidelines. Actual prices are negotiated and agreed upon in individual purchase orders and are typically set at market prices based on the quality grade and quantities determined and agreed with the suppliers. Prices may vary based on market demand, crop condition, etc. The Company can generally secure the premium quality raw material supplies at prices slightly higher than the typical market prices for average quality raw materials. The quality of supplies must meet standardized specifications of both the mushroom industry and standards set by the Company.

 

The Company advances certain initial payments based on its estimated purchase plan from these suppliers and additional advances based on individual purchase orders placed. The Company pays advances solely to secure an adequate supply of dried mushrooms to meet its sales demands. The Company’s purchase orders require that the advances shall be refunded by suppliers if they fail to produce the contracted volume of dried mushrooms or fail to deliver supplies to the Company timely.

 

Advances to suppliers are carried at cost and evaluated for recoverability. The realizability evaluation process is similar to that of the lower of cost or net realizable value evaluation process for inventories. The Company periodically evaluates its advances for recoverability by monitoring suppliers’ ability to deliver a sufficient supply of mushrooms as well as current crop and market condition. This includes analyzing historical quantity and quality of production with monitoring of crop information provided by the Company’s field personnel related to weather or disaster or any other reason. If for any reason the Company believes that it will not receive supplies of the contracted volumes, the Company will assess its advances for any likelihood of recoverability and adjust advances on its financial statements at the lower of cost or estimated recoverable amounts. The advances are made primarily to these suppliers, which are co-operatives formed by many family farms, with which the Company has had long-term relationships over the years. If any of these family farms fail to deliver supplies, the Company would expect to receive a refund of the advances through these suppliers. The Company accrues for any allowance for possible loss on advances when there is doubt as to the collectability of the refund.

 

During the six months ended March 31, 2026, the Company recognized an additional allowance of approximately $31.7 million on advances to suppliers. As of March 31, 2026 and September 30, 2025, the total allowance for advances to suppliers was approximately $42.6 million and $10.1 million, respectively. The additional allowance recognized during the period was primarily attributable to management's strategic decision to substantially reduce and exit certain operations in the PRC, as a result of which the Company no longer expected to utilize a significant portion of these advances through future purchases.

 

 
F-22

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 5 — Note receivable

 

 

 

As of

 

 

As of

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(audited)

 

Note receivable, current portion

 

$ 16,098,885

 

 

$ 31,005,260

 

Note receivable, non-current portion

 

 

19,676,415

 

 

 

28,620,240

 

Total

 

$ 35,775,300

 

 

$ 59,625,500

 

 

On February 28, 2025, Farmmi International Limited (“Farmmi International” or the “Buyer”), a wholly-owned subsidiary of Farmmi, Inc. (the “Company”), entered into an equity transfer agreement with Malong Limited, a Hong Kong company (the “Seller”) to acquire 45% equity of Ewayforest Group Limited (the “Target”), a Hong Kong company and a wholly owned subsidiary of the Seller. The Target owns 100% of the equity of Lishui Ganglisen Enterprise Management Co., Ltd, a Chinese company, which in turn owns 100% of the equity of Lishui Senbo Forestry Co., Ltd, a Chinese company (“Senbo Forestry”). Senbo Forestry is engaged in forestry management, improvement, planting and product sales. The Target had an appraised value of approximately RMB1.6 billion (approximately $220.2 million) as of December 31, 2024 based on an asset appraisal report issued by an independent third party appraisal firm.

 

Pursuant to the agreement, Farmmi International would pay a total purchase price of RMB723,324,150 ($99,676,733) for 45% of the Target’s equity (the “Equity”). The parties had agreed that the Buyer would pay $35 million in cash and $35 million in the form of accounts receivable by March 31, 2025, with the remaining purchase price of $29,085,500 to be settled by September 2025. The parties had further agreed the date on which the Seller received the first installment of the purchase price should be deemed the closing date of the transaction. Within one month after receiving the first installment of the purchase price, the Seller should complete the procedures for amending the Target’s articles of association and transferring the Equity. The Target was also required to have a two-member board of directors with one director appointed by each of the Buyer and the Seller. The agreement contains customary representations, warranties and covenants of the Buyer and the Seller, and is subject to certain customary closing conditions. However, due to the inability to obtain the Forest Ownership Certificate, the ownership of the relevant assets could not be confirmed. On September 30, 2025, both parties agreed to terminate the original asset/equity acquisition transaction and reached an agreement regarding the refund of the already paid consideration. The acquisition consideration to be refunded to the Company includes accounts receivable amounting to $35 million, and the cash portion of the consideration amounting to $59,625,500. As of September 30, 2025, accounts receivable of $35 million was reverted to the Company.

 

Both parties agree that 40% of the cash consideration of $59,625,500, amounting to $23,850,200, shall be refunded by the Seller to the Buyer in a lump sum before January 31, 2026. The Company received $23,850,200 on January 27, 2026.

 

Both parties agree that 60% of the cash consideration of $59,625,500, totaling $35,775,300, shall be repaid by the Seller in installments to the Buyer. The specific arrangement is as follows:

 

(1) The repayment period is two (2) years, from February 1, 2026 to January 30, 2028.

 

(2) Interest is calculated at an annualized rate of 2%, with interest to be paid once per quarter. Interest is calculated on a daily basis based on the specific outstanding balance.

 

(3) The principal is to be repaid every six months, with the specific time and amount as follows:

 

From February 1, 2026 to July 30, 2026, a total of no less than 20% shall be returned during this period:

 

From August 1, 2026 to January 30, 2027, a total of no less than 25% shall be returned;

 

From February 1, 2027 to July 30, 2027, a total of no less than 25% shall be returned;

 

From August 1, 2027 to January 30, 2028, the balance to be settled during this period.

 

 
F-23

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 6 — Inventories

 

Inventories consisted of the following:

 

 

 

As of

 

 

As of

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(audited)

 

Finished goods

 

 

-

 

 

$ 1,544,462

 

Inventories

 

 

-

 

 

$ 1,544,462

 

 

As of March 31, 2026 and September 30, 2025, allowance for inventory reserve was nil and nil, respectively.

 

Note 7Other current assets

 

Other current assets consisted of the following: 

 

 

 

As of

 

 

As of

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(audited)

 

Security deposits

 

$ 1,041,476

 

 

$ 28,000

 

Advances to third parties

 

 

1,403,292

 

 

 

989,986

 

Prepaid expenses

 

 

24,787

 

 

 

9,900

 

Prepaid value-added tax

 

 

30,675

 

 

 

29,723

 

Sub-total

 

 

2,500,230

 

 

 

1,057,609

 

Less: allowance for credit losses

 

 

(775,616 )

 

 

(685,345 )

Other current assets, net

 

$ 1,724,614

 

 

$ 372,264

 

 

The movement of allowance for credit losses was as follows:

 

 

 

For the Six

 

 

For the

 

 

 

Months Ended

 

 

Year Ended

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(audited)

 

Balance as of beginning of period

 

$ 685,345

 

 

 

-

 

Additions

 

 

67,260

 

 

 

676,460

 

Translation adjustments

 

 

23,011

 

 

 

455

 

Balance as of end of period

 

$ 775,616

 

 

$ 685,345

 

 

 
F-24

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 8 — Long-term investments, net

 

Long-term investments of the Company relate to investment of RMB50 million (approximately $7.1 million) in Shanghai Zhong Jian Yiting Medical Health Technology Partnership (“Partnership”) as a Limited Partner (“LP”) with a third party, Zhong Jian (Lishui) Business Management Co., Ltd., who is a General Partner (“GP”) or the executive partner in the Partnership and GP has decision-making authority in significant financial and operating decisions of the Partnership, and investment of RMB1 million (approximately $0.1 million) in 10% equity of Zhejiang Yili Yuncang Technology Group Co., Ltd

 

Long-term investments, net of impairment, are as follows:

 

 

 

 As of

 

 

 As of

 

 

 

 March 31,

 

 

 September 30,

 

 

 

 2026

 

 

 2025

 

 

 

 (unaudited)

 

 

 (audited)

 

Long-term investments

 

$ 7,393,447

 

 

$ 7,163,928

 

Less: impairment

 

 

(7,393,447 )

 

 

(231,524 )

Total

 

 

-

 

 

$ 6,932,404

 

 

An impairment charge is recorded when the carrying amount of the investment exceeds its fair value and this condition is determined to be other-than-temporary. As of March 31, 2026 and September 30, 2025, impairment for long-term investments was $7,393,447 which includes foreign exchange translation of $ 117,807 and $231,524, respectively.

 

Note 9 — Loan to a third party

 

The loan to a third party relates to a three-year $10 million revolving loan to a third party for working capital purposes from November 1, 2025 to October 30, 2028 and at a 2% interest rate per annum. For the six months ended March 31, 2026, loan to this third party was $3,842,464 and the repayment from this loan was $1,244,431. As of March 31, 2026, the outstanding amount was $2,598,033.

 

Note 10 — Security deposits

 

Security deposits relate to rental deposits paid to two third-party landlords for leasing warehouse spaces. These leases have expiry dates ranging from June 2030 to January 2031.

 

Note 11 — Property and equipment, net

 

Property and equipment, stated at cost less accumulated depreciation, consisted of the following:

 

 

 

As of

 

 

As of

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(audited)

 

Machinery and equipment

 

$ 418,763

 

 

 

-

 

Transportation equipment

 

 

29,450

 

 

 

29,450

 

Office equipment

 

 

16,686

 

 

 

16,672

 

Subtotal

 

 

464,899

 

 

 

46,122

 

Accumulated depreciation

 

 

(46,201 )

 

 

(9,342 )

Total

 

$ 418,698

 

 

$ 36,780

 

 

Depreciation expense was $36,854 and $8,863 for the six months ended March 31, 2026 and 2025, respectively.

 

 
F-25

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 12— Promissory note

 

On July 30, 2024, the Company entered into a note purchase agreement (the “Purchase Agreement”) with Atlas Sciences, LLC, a Utah limited liability company (the “Investor”), pursuant to which the Company issued to the Investor an unsecured promissory note (the “Note”) dated July 30, 2024 in the original principal amount of $5,355,000 (the “Note”) for $5,000,000 in gross proceeds. The Company used all of the proceeds from the Note to repay its indebtedness owed to Streeterville Capital, LLC under the Convertible Promissory Note issued on September 26, 2022.

 

The Note bears interest at a rate of 7.0% per year and has a term of twelve (12) months after the purchase price of the Note is delivered by the Investor (the “Purchase Price Date”). The Note carries an original issue discount of $350,000 and includes $5,000 for investor fees, costs, and other transaction expenses incurred in connection with the purchase and sale of the Note. The Company may prepay all or a portion of the Note at any time by paying 105% of the outstanding balance elected for pre-payment. The Investor has the right to redeem the Note at any time six (6) months after the Purchase Price Date, subject to a maximum monthly redemption amount of $1,000,000. Following receipt of a redemption notice, if the Company has not repaid by a minimum monthly redemption amount of $250,000, the Company is required to pay by the fifth day of the following month the difference between the minimum monthly redemption amount and the amount actually repaid in such month, or the outstanding balance will be automatically increased by 0.5% as of such fifth day. Under the Purchase Agreement, while the Note is outstanding until 5 days after the Note is satisfied in full, the Company agreed to keep adequate current public information available, maintain its Nasdaq listing and not make certain Restricted Issuance (as defined therein), among other things. Upon the occurrence of a Trigger Event (as defined in the Note), the Investor shall have the right to increase the balance of the Note by 10% for a Major Trigger Event (as defined in the Note) and 5% for a Minor Trigger Event (as defined in the Note), with an aggregate of 25% as the maximum increase in the outstanding balance. In addition, the Note provides that upon occurrence of an Event of Default, the interest rate shall accrue on the outstanding balance at the rate equal to the lesser of 15% per annum or the maximum rate permitted under applicable law.

 

The foregoing descriptions of the Purchase Agreement and the Note are summaries of the material terms of such agreements and do not purport to be complete and are qualified in their entirety by reference to the form of the Purchase Agreement and the Note.

 

For the six months ended March 31, 2026, neither ordinary share was issued nor payment was made for the repayment of the Note. For the six months ended March 31, 2025, 100,182 ordinary shares were issued for the redemption $338,009 of the Note and $1 million in cash was paid for the repayment of the Note. As of March 31, 2026 and September 30, 2025, the balance of the Note amounted to approximately $2.5 million and $2.5 million , respectively.

 

For the six months ended March 31, 2026 and 2025, the interest expense of the Note was $89,630 and $159,829, respectively, and the amortization of debt issuance costs was nil and $177,014, respectively.

 

Note 13 — Other current liabilities

 

Other current liabilities consisted of the following:

 

 

 

As of

 

 

As of

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(audited)

 

Accrued expenses

 

$ 1,049,359

 

 

$ 697,520

 

Contract liabilities

 

 

484,862

 

 

 

602,721

 

Security deposits

 

 

1,335,537

 

 

 

582,161

 

Taxes payable

 

 

102,735

 

 

 

99,546

 

Interest payable

 

 

83,227

 

 

 

74,684

 

Salaries payable

 

 

42,240

 

 

 

40,039

 

Total

 

$ 3,097,960

 

 

$ 2,096,671

 

 

Note 14 — Long-term loan

 

Long-term loan consisted of the following:

 

 

 

As of

 

 

As of

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

Long-term loan, non-current portion

 

(unaudited)

 

 

(audited)

 

Xinmao Group Co., Ltd.

 

 

-

 

 

$ 1,809,780

 

Total long-term loan, non-current portion

 

 

-

 

 

$ 1,809,780

 

 

The following table summarizes the loan commencement date, loan maturity date, and the effective annual interest rate of the unsecured long-term loan:

 

 

 

Loan

 

Loan

 

Effective

 

 

 

 

 

commencement

 

maturity

 

interest

 

 

 

Long-term loans, non-current portion

 

date

 

date

 

rate

 

 

Note

 

Xinmao Group Co., Ltd.

 

May 1, 2024

 

April 30, 2027

 

 

4.50 %

 

 

1

 

 

1.

On January 1, 2024, the Company entered into a revolving loan of $5.0 million with a third party, with a flexible drawdown and repayment terms from May 1, 2024 to April 30, 2027, and with an annual interest of 4.5% per annum. This loan was fully repaid in March 2026 and the Company lent $2,598,033 to Xinmao Group Co., Ltd. as of March 31, 2026.

 

For the six months ended March 31, 2026 and 2025, the interest expense was $7,277 and $71,876, respectively.

 

 
F-26

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 15 — Shareholders’ equity

 

Ordinary shares

 

Farmmi, Inc. (the “Company”) convened its extraordinary general meeting of shareholders on December 5, 2025, and passed special resolutions that

 

1.

The authorized shares, and the issued and outstanding shares, of the Company be reclassified and redesignated into Class A Ordinary Shares and Class B Ordinary Shares (the “Redesignation”);

 

 

2.

The Fourth Amended and Restated Memorandum and Articles of Associations of the Company be adopted (the “Amended and Restated Memorandum and Articles”);

 

 

3.

The authorized share capital of the Company be amended from (i) US$12,000,000,000 divided into 5,000,000,000 Ordinary Shares of US$2.40 nominal or par value each, to (ii) US$12,000,000,000 divided into 4,500,000,000 Class A Ordinary Shares of US$2.40 nominal or par value each with one vote per share (the “Class A Ordinary Shares”), and 500,000,000 Class B Ordinary Shares of US$2.40 nominal or par value each with fifty votes per share (the “Class B Ordinary Shares”), by the redesignation of 4,500,000,000 Ordinary Shares into 4,500,000,000 Class A Shares of US$2.40 nominal or par value each, and the redesignation of 500,000,000 Ordinary Shares into 500,000,000 Class B Shares with a nominal or par value of US$2.40 each.

 

 

 

The terms of, and rights attaching to the Class A Ordinary Shares and the Class B Ordinary Shares will be materially identical to the existing Ordinary Shares of par value US$2.40 each in the capital of the Company save that the Class B Ordinary Shares: (i) shall have 50 times the voting rights per share of Class A Ordinary Shares, and (ii) shall be convertible into Class A Ordinary Shares, as provided in the Fourth Amended and Restated Memorandum and Articles of Association.

 

 

4.

Simultaneously with the Redesignation, the Ordinary Shares in the Company issued and outstanding be redesignated as follows:

 

 

-

all the existing authorized and issued Ordinary Shares of the Company be redesignated as Class A Ordinary Shares save for 3,873 Ordinary Shares issued and currently registered in the name of Farmnet Limited; and

 

-

the 3,873 Ordinary Shares held by Farmnet Limited be redesignated as 3,873 Class B Ordinary Shares.

 

The Company convened an extraordinary general meeting of shareholders on February 24, 2026, and passed a special resolution that, subject to and conditional upon compliance at all times with the Companies Act of the Cayman Islands (Revised) in respect of the Capital Reduction, the authorized share capital of the Company be reduced from (i) US$12,000,000,000 divided into 4,500,000,000 Class A Ordinary Shares of US$2.40 nominal or par value each, and 500,000,000 Class B Ordinary Shares of US$2.40 nominal or par value each, to (ii) US$50 divided into 4,500,000,000 Class A Ordinary Shares of US$0.00000001 nominal or par value each, and 500,000,000 Class B Ordinary Shares of US$0.00000001 nominal or par value each, by the reduction of the par value of each Class A share and each Class B share by US$2.39999999 (the “Capital Reduction”).

 

The Capital Reduction has taken effect following the registration of the Special Resolution with the Cayman Islands Registrar of Companies on February 24, 2026.

 

For the six months ended March 31, 2026, 8,333,334 ordinary shares were issued on November 22, 2025 in connection with exercise of warrant C and the redesignation of 1,791 Class A ordinary shares as 1,791 Class B ordinary shares. In connection with the exercise of warrant C, the Company received $2,000,000 in March 2026, and the remaining $18,000,002 was received in June 2026. In connection with the redesignation of Class A ordinary shares as Class B ordinary shares, an additional 2,082 Class A ordinary shares was redesignated as 2,082 Class B ordinary shares on April 22, 2026.

 

 
F-27

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

For the six months ended March 31, 2025, 100,182 ordinary shares were issued for the redemption of $338,009 promissory notes and 325,825 ordinary shares were issued for the exercise of $781,980 warrants.

 

Statutory reserve

 

The Company is required to make appropriations to reserve funds, comprising the statutory surplus reserve and discretionary surplus reserve, based on after-tax net income determined in accordance with generally accepted accounting principles of the PRC (“PRC GAAP”).

 

Appropriations to the statutory surplus reserve are required to be at least 10% of the after-tax net income determined in accordance with PRC GAAP until the reserve is equal to 50% of the entities’ registered capital. Appropriations to the discretionary surplus reserve are made at the discretion of the Board of Directors. As of March 31, 2026 and September 30, 2025, the balance of the required statutory reserves was $0.7 million and $0.7 million, respectively.

 

Warrants

 

2024 warrants - Series A

 

On August 22, 2024, Farmmi and certain institutional purchasers entered into a securities purchase agreement, pursuant to which the Company agreed to sell to such purchasers an aggregate of 3,433,167 ordinary shares, par value $0.20 per share, in a registered direct offering and Series A warrants to purchase up to 3,433,167 Ordinary Shares in a concurrent private placement for gross proceeds of approximately $1.03 million before deducting the placement agent’s fees and other estimated offering expenses. In connection with this offering, on August 26, 2024, 3,433,167 warrants were issued with an exercise price of $0.75, exercisable immediately, which expire five years after their issuance date on August 26, 2024 (i.e., August 25, 2029). On December 6, 2024, the warrant was adjusted to an exercise price of $0.20 (or $2.40 after adjusted for the effect of the reverse share split) and, correspondingly, the number of warrants adjusted to 12,874,377 (or 1,072,865 after adjusted for the effect of the reverse share split). As of September 30, 2025, 325,825 warrants were exercised for proceeds of $781,980. As of September 30, 2024, no warrant was exercised. As of March 31, 2026 and September 30, 2025, 747,040 and 747,040 warrants, respectively, were outstanding, out-of-money and antidilutive.

 

2025 warrants - Series C

 

On August 4, 2025, the Company entered into a definitive securities purchase agreement, (the "Purchase Agreement") with certain accredited investors (“Selling Shareholders”), pursuant to which the Company offered to sell to the Selling Shareholders an aggregate of 4,166,667 Ordinary Shares, par value $2.4 per share, of the Company and Series C warrants to purchase up to 8,333,334 Ordinary Shares in a private placement for gross proceeds of $10.0 million (the “August 2025 PIPE”). The Offering closed on August 6, 2025. The Warrants are exercisable immediately following issuance at an initial exercise price of $2.40 per ordinary share and expire 3 years from the date of issuance. The exercise price and the number of ordinary shares issuable upon the exercise of the Warrants, or the Warrant Shares, are subject to adjustment upon the occurrence of certain events, including stock dividends or share splits, business combination, other recapitalization transactions or similar transactions. Upon such reset of the exercise price, the number of Warrant Shares will be proportionately increased such that the aggregate exercise price payable for the adjusted number of Warrant Shares will be the same as the aggregate exercise price on the date of issuance for the Warrant Shares then outstanding. In addition, subject to the rules and regulations of the Principal Market, the Company may at any time during the term of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of the Company. For the six months ended March 31, 2026, 8,333,334 ordinary shares were issued on November 22, 2025 in connection with exercise of warrant C and, as of March 31, 2026, nil Series C warrant was outstanding.

 

The following tables summarize the warrants issued, outstanding, and expired as of and for the six months ended March 31, 2026 and for the year ended September 30, 2025.

 

 

 

 

 

Exercised

 

 

 

Warrants

 

 

price

 

Warrants outstanding, as of September 30, 2024

 

 

1,072,865

 

 

$ 2.40

 

Issued

 

 

8,333,334

 

 

$ 2.40

 

Exercised

 

 

(325,825 )

 

$ 2.40

 

Expired

 

 

-

 

 

 

-

 

Warrants outstanding, as of September 30, 2025

 

 

9,080,374

 

 

$ 2.40

 

Issued

 

 

-

 

 

 

-

 

Exercised

 

 

(8,333,334 )

 

$ 2.40

 

Expired

 

 

-

 

 

 

-

 

Warrants outstanding, as of March 31, 2026

 

 

747,040

 

 

$ 2.40

 

Warrants exercisable, as of March 31, 2026

 

 

747,040

 

 

$ 2.40

 

 

 

 

 

 

 

 

Remaining

 

 

 

Warrant

 

 

Exercise

 

 

contractual

 

Warrants Outstanding

 

exercisable

 

 

price

 

 

life

 

2024 warrants -Series A

 

 

747,040

 

 

$ 2.40

 

 

3.4 years

 

 

 
F-28

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1— Concentration of major customers and suppliers

 

For the six months ended March 31, 2026, one major customer accounted for approximately 57.9% of the Company’s total sales. For the six months ended March 31, 2025, two major customers accounted for approximately 68% and 12% of the Company’s total sales, respectively. Any decrease in sales to these major customers may negatively impact the Company’s operations and cash flows if the Company fails to increase its sales to other customers.

 

As of March 31, 2026, one major customer accounted for approximately 98.7% of the Company’s accounts receivable balance. As of September 30, 2025, one major customer accounted for approximately 99.7% of the Company’s accounts receivable balance.

 

For the six months ended March 31, 2026, five major suppliers accounted for approximately 24%, 21%, 13%, 11%, and 10% of the total purchases, respectively. For the six months ended March 31, 2025, three major suppliers accounted for approximately 33%, 32%, and 17% of the total purchases, respectively.

 

As of March 31, 2026, three major suppliers accounted for approximately 44%, 43%, and 13% of the Company’s advances to suppliers’ balance, respectively. As of September 30, 2025, three major suppliers accounted for approximately 42%, 30%, and 29% of the Company’s advances to supplier’ balance.

 

 
F-29

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 17 — Leases

 

The Company rents (i) its factories in Lishui City, Zhejiang Province from a related party, Zhejiang Tantech Bamboo Technology Co., Ltd, for processing dried edible fungi; (ii) a floor in an office building in Hangzhou from a third party; and (iii) three warehouses in the USA.

 

As of March 31, 2026 and September 30, 2025, the remaining average lease term was an average of 4.1 years and 4.3 years, respectively. The Company’s lease agreements do not provide a readily determinable implicit rate nor is it available to the Company from its lessors. Instead, the Company estimates its incremental borrowing rate based on actual incremental borrowing interest rates from financial institutions in order to discount lease payments to present value. The weighted average discount rate of the Company’s operating leases was 14.6% per annum and 14.6% per annum, as of March 31, 2026 and September 30, 2025, respectively.

 

Supplemental balance sheet information related to operating leases was as follows:

 

 

 

As of

 

 

As of

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(audited)

 

Right-of-use assets under operating leases

 

$ 14,166,214

 

 

$ 16,440,531

 

 

 

 

 

 

 

 

 

 

Operating lease liabilities, current

 

 

3,690,692

 

 

 

5,030,911

 

Operating lease liabilities, non-current

 

 

10,475,522

 

 

 

11,409,620

 

Total operating lease liabilities

 

$ 14,166,214

 

 

$ 16,440,531

 

 

 

 

As of

 

 

 

March 31,

 

For the years ending September 30,

 

2026

 

For the remaining months of fiscal year 2026

 

$ 3,662,509

 

2027

 

 

3,457,153

 

2028

 

 

3,559,700

 

2029

 

 

3,669,199

 

2030

 

 

3,569,391

 

Thereafter

 

 

1,002,553

 

Total future minimum lease payments

 

 

18,920,505

 

Less: Imputed interest

 

 

(4,754,291 )

Total

 

$ 14,166,214

 

 

 
F-30

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 18 — Segment reporting

 

In accordance with ASC 280, Segment Reporting, operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”), or decision-making Company, in deciding how to allocate resources and in assessing performance. The Company uses the “management approach” in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker for making operating decisions and assessing performance as the source for determining the Company’s reportable segments. The Company’s CODM has been identified as the chief executive officer (the “CEO”), who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company.

 

The Company currently has three main products from which revenue is earned and expenses are incurred: shiitake mushrooms, mu er fungus, and other edible fungi and other agricultural products. The operations of these product categories have similar economic characteristics. In particular, the Company uses the same or similar production processes, sells to the same or similar type of customers, and uses the same or similar methods to distribute these products. The resources required by these products share high similarity. Switching cost between different products is minimal. Production is primarily determined by sales orders received and market trends. Therefore, management, including the chief operating decision maker, primarily relies on the revenue data of different products in allocating resources and assessing performance. Based on management’s assessment, the Company has determined that it has only two operating segments and therefore two reportable segments as defined by ASC 280. Since June 2021, the Company’s operations have expanded into bulk agricultural commodity trading, such as cotton and corn bulk trading. The Company obtains control over these commodities as a principal from its suppliers before selling these commodities to its customers. To implement global expansion strategy and meet the growing customer demand, the Company launched its warehouse and logistics services business in the U.S. in the summer of 2024, with the aim to develop a food and agricultural product supply chain system. In July 2024, Farmmi USA opened its first warehouse and logistics services base in Chino, California, through the lease of warehouse spaces of 315,000 square feet from a large facility managed by established logistics companies. The facility provides special railway lines that offer sea-railway cargo transportation services. The logistics services provided to customers include cargo transfers and bonded warehouses. In March 2025, the Company further expanded its logistics service operations to the U.S. East Coast by opening a new warehouse located within an industrial park in Somerset, New Jersey. In August 2025, the Company leased additional warehouse spaces of approximately 183,000 square feet located in Robbinsville, New Jersey, bringing its total warehouse footprint in the U.S. to 640,000 square feet. In January 2026, the U.S. subsidiary completes a Food Facility Registration with the U.S. Food and Drug Administration and has the capacity to support the storage and distribution of a wide range of foods and agricultural commodities.

 

Revenue disaggregation

 

Management has concluded that the disaggregation level is the same under both the revenue standard and the segment reporting standard. Revenue under the segment reporting standard is measured on the same basis as under the revenue standard. The Company’s disaggregation of revenue for the six months ended March 31, 2026 and 2025, respectively:

 

 

 

For the Six Months Ended

March 31,

 

 

 

2026

 

 

2025

 

Revenue recognition at a point in time

 

(unaudited)

 

 

(unaudited)

 

Sales of agricultural products

 

 

 

 

 

 

Shiitake

 

$ 1,854,057

 

 

$ 6,668,963

 

Mu Er

 

 

1,846,572

 

 

 

5,255,756

 

Other products

 

 

-

 

 

 

29,109

 

Agricultural products trading business

 

 

 

 

 

 

 

 

Corn

 

 

-

 

 

 

782,946

 

Logistic services

 

 

 

 

 

 

 

 

Operation services

 

 

210,096

 

 

 

684,444

 

Special work order services

 

 

588,887

 

 

 

205,573

 

Sub-total

 

 

4,499,612

 

 

 

13,626,791

 

Revenue recognition over time

 

 

 

 

 

 

 

 

Logistic services

 

 

 

 

 

 

 

 

Outbound delivery services

 

 

1,288,398

 

 

 

2,407,024

 

Storage services

 

 

606,703

 

 

 

110,494

 

Total

 

$ 6,394,713

 

 

$ 16,144,309

 

 

 

 

For the Six Months Ended

March 31,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(unaudited)

 

Products revenue

 

$ 3,700,629

 

 

$ 12,736,774

 

Services revenue

 

 

2,694,084

 

 

 

3,407,535

 

Total

 

$ 6,394,713

 

 

$ 16,144,309

 

 

 
F-31

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Revenue by geographical segment for the six months ended March 31, 2026 and 2025:

 

For the Six Months Ended

March 31,

2026

2025

(unaudited)

(unaudited)

PRC

$ 3,700,629 $ 12,736,774

United States of America

2,694,084 3,407,535

Total

$ 6,394,713 $ 16,144,309

 

 

 

For the Six Months Ended

March 31, 2026

 

 

 

USA

 

 

PRC

 

 

Total

 

Revenues

 

$ 2,694,084

 

 

$ 3,700,629

 

 

$ 6,394,713

 

Cost of revenues

 

 

(4,134,939 )

 

 

(3,349,148 )

 

 

(7,484,087 )

Gross (loss) profit

 

 

(1,440,855 )

 

 

351,481

 

 

 

(1,089,374 )

Operating expenses

 

 

(1,234,769 )

 

 

(36,202,818 )

 

 

(37,437,587 )

Loss from operations

 

 

(2,675,624 )

 

 

(35,851,337 )

 

 

(38,526,961 )

Other income (expenses)

 

 

936,903

 

 

 

(363 )

 

 

936,540

 

Loss before income taxes

 

 

(1,738,721 )

 

 

(35,851,700 )

 

 

(37,590,421 )

Income tax expenses

 

 

-

 

 

 

-

 

 

 

-

 

Net loss

 

$ (1,738,721 )

 

$ (35,851,700 )

 

$ (37,590,421 )

 

For the Six Months Ended

March 31, 2025

USA

PRC

Total

Revenues

$ 3,407,535 $ 12,736,774 $ 16,144,309

Cost of revenues

(3,953,543 ) (11,376,192 ) (15,329,735 )

Gross (loss) profit

(546,008 ) 1,360,582 814,574

Operating expenses

(1,246,178 ) (237,140 ) (1,483,318 )

(Loss) income from operations

(1,792,186 ) 1,123,442 (668,744 )

Other income (expenses)

495,006 (77,920 ) 417,086

(Loss) income before income taxes

(1,297,180 ) 1,045,522 (251,658 )

Income tax expenses

- - -

Net (loss) income

$ (1,297,180 ) $ 1,045,522 $ (251,658 )

 

As of March 31, 2026 and September 30, 2025, the Company’s long-lived assets are located in PRC and the United States of America:

 

 

 

As of

 

 

As of

 

 

 

March 31,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

 

(unaudited)

 

 

(audited)

 

United States of America

 

$ 37,706,764

 

 

$ 46,933,699

 

PRC

 

 

34,227

 

 

 

6,973,528

 

Total long-lived assets

 

$ 37,740,991

 

 

$ 53,907,227

 

 

 
F-32

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 19 — Related party transactions

 

The relationship and the nature of related party transactions are summarized as follows:

 

Name of related party

Relationship to the Company

Nature of transactions

Zhejiang Tantech Bamboo Technology Co., Ltd

Under common control of Mr. Zhengyu Wang and Ms. Yefang Zhang, CEO of the Company

Lease factory building to the Company and charging water and electricity for offices leased to the Company.

Yefang Zhang

Chief Executive Officer of the Company

Payment of expenses for the Company.

Zhengyu Wang

Mr. Zhengyu Wang is Ms. Yefang Zhang's husband

Non-competition agreement

Centurynew USA Inc

CEO Yefang Zhang controls the company.

Payment of expenses for the Company.

Epakia Inc.

A Subsidiary of Tantech Holdings Ltd Group. Yefang Zhang serves as a Chairwoman of the board of directors of Tantech Holdings Ltd

Payment of expenses for the related party

 

Due from a related party

 

Due from a related party consisted of the following:

 

 

 

 

As of

 

 

As of

 

 

 

 

March 31,

 

 

September 30,

 

 

 

 

2026

 

 

2025

 

Due from related parties

 

Name of related parties

 

(unaudited)

 

 

(audited)

 

Other receivables

 

Epakia Inc.

 

$ 35,000

 

 

 

-

 

Total

 

 

 

$ 35,000

 

 

 

-

 

 

Amount due from Epakia Inc. was related to payment of expenses on behalf of a related party. Amount was due on demand and non-interest bearing.

 

Due to related parties

 

Due to related parties consisted of the following:

 

 

 

 

As of

 

 

As of

 

 

 

 

March 31,

 

 

September 30,

 

 

 

 

2026

 

 

2025

 

Due to related parties

 

Name of related parties

 

(unaudited)

 

 

(audited)

 

Other payable

 

Centurynew USA Inc

 

$ 3,600,008

 

 

 

-

 

Other payable

 

Yefang Zhang

 

 

227,773

 

 

$ 241,773

 

Other payable

 

Zhejiang Tantech Bamboo Technology Co., Ltd.

 

 

64,232

 

 

 

52,146

 

Total

 

 

 

$ 3,892,013

 

 

$ 293,919

 

 

Amount due to Centurynew USA Inc and Yefang Zhang was related to payment of expenses by related parties for the Company. Amounts were due on demand and non-interest bearing.

 

Amount due to Zhejiang Tantech Bamboo Technology Co., Ltd. was related to lease, water and electricity expenses for offices leased to the Company.

 

Sales to related parties

 

The Company periodically sells merchandise to its affiliates during the ordinary course of business. For the six months ended March 31, 2026, and 2025, the Company recorded sales to related parties of nil and $137, respectively.

 

Operating leases from related parties

 

The following table summarizes operating leases with related party, Zhejiang Tantech Bamboo Technology Co., Ltd, detailing lease begin date, lease end date, leasing purpose, leasing area in square meters, and annual rent in RMB and its equivalent in USD.

 

Zhejiang Tantech Bamboo Technology Co., Ltd.

 

 Lease No 1

 

Lease begin date

 

March 1, 2023

 

Lease end date

 

February 29, 2028

 

Leasing purpose

 

Office

 

Annual rent in RMB

 

 

131,835

 

Annual rent in USD

 

$ 18,817

 

Area (in square meters)

 

 

479

 

 

For the six months ended March 31, 2026, and 2025, the Company incurred lease expenses of $9,409 and $38,258, respectively.

 

Non-Competition Agreement

 

The Company and Forasen Group signed a Non-Competition Agreement which provides that Forasen Group should not engage in any business that the Company engages in, except purchasing products from us. In addition, Mr. Wang and Ms. Zhang signed a Non-Competition Agreement with the Company and Tantech which provides that Mr. Wang and Ms. Zhang shall not vote in favor or otherwise cause Tantech to engage in the business that the Company conducts.

 

 
F-33

Table of Contents

 

FARMMI, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 20 — Subsequent events

 

Management has reviewed events occurring through the date the unaudited condensed consolidated financial statements were issued and, except as disclosed elsewhere in the unaudited condensed consolidated financial statements, no subsequent events occurred that require accrual or disclosure, except for:

  

1.

On June 15, 2026, the Company completed an exercise price adjustment to the outstanding Series A warrant pursuant to the provisions of such warrants. Following such exercise price adjustment, there are 1,304,689 Series A warrants outstanding, each exercisable at $1.3742 per share.

 

 

2.

On June 16, 2026, the Company entered into a securities purchase agreement with certain investors, pursuant to which the Company agreed to issue and sell to such purchasers, in a registered direct offering, an aggregate of 16,571,429 Class A ordinary shares, at an offering price of $0.35 per share, for gross proceeds of $5.8 million before deducting offering expenses. The offering closed on June 17, 2026.

 

 

3.

On June 29, 2026, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp., as the sole underwriter (the “Underwriter”), pursuant to which the Company agreed to issue and sell to the Underwriter, in a underwritten public shelf takedown offering, an aggregate of 7,000,000 Class A ordinary shares and pre-funded warrants to purchase 5,000,000 ordinary shares (the “Pre-Funded Warrant”). Gross proceeds to the Company were approximately $3.0 million, before deducting underwriting fees and other offering expenses payable by the Company. The offering closed on June 30, 2026.

 

 

4.

The Company entered into an exchange agreement with Atlas Sciences, LLC on April 13, 2026, August 11, 2026, August 14, 2026, and August 17, 2026, respectively. Pursuant to each agreement, the parties agreed to partition a new promissory note (each, a “New Note”) from the promissory note the Company issued to Atlas Sciences on July 30, 2024, in the original principal amount of $5,355,000, and to exchange each partitioned New Note for the Company’s Class A Ordinary Shares. Pursuant to the agreements, the Company exchanged: (i) a partitioned New Note in the principal amount of $50,000 for the issuance of 51,313 shares on April 16, 2026, (ii) a New Note in the principal amount of $200,000 for the issuance of 1,581,027 shares on August 12, 2026, (iii) a New Note in the principal amount of $175,000 for the issuance 1,649,387 shares on August 14, 2026, and (iv) a New Note in the principal amount of $180,000 for the issuance 1,757,812 shares on August 17, 2026.

 

 
F-34
EX-99.2 3 fami_ex992.htm MANAGEMENTS DISCUSSION AND ANALYSIS fami_ex992.htm

EXHIBIT 99.2

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited condensed consolidated financial statements and the related notes that appear elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of various factors. Forward-looking statements speak only as of the date of this report. You should not put undue reliance on any forward-looking statements. We strongly encourage investors to carefully read the factors described in our annual report on Form 20-F in the section entitled “Risk Factors” for a description of certain risks that could, among other things, cause actual results to differ from these forward-looking statements.

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This report contains forward-looking statements. All statements contained in this report other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in the “Risk Factors” section. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

 

 
1

 

 

Results of Operations for the Six Months Ended March 31, 2026 and 2025

 

The following table summarizes our results of operations for the six months ended March 31, 2026 and 2025:

 

 

 

 For the Six Months Ended

March 31,

 

 

 Variance

 

 

 

 2026

 

 

 2025

 

 

 Amount

 

 

 %

 

Revenue

 

$ 6,394,713

 

 

$ 16,144,309

 

 

$ (9,749,596 )

 

(60.4)

%

Cost of revenues

 

 

(7,484,087 )

 

 

(15,329,735 )

 

 

(7,845,648 )

 

(51.2)

%

Gross (loss) profit

 

 

(1,089,374 )

 

 

814,574

 

 

 

(1,903,948 )

 

(233.7)

%

(Allowance for) reversal of allowance for credit losses

 

 

(29,065,008 )

 

 

270,832

 

 

 

29,335,840

 

 

 

10,831.7 %

Long-term investment impairment loss

 

 

(7,044,116 )

 

 

-

 

 

 

7,044,116

 

 

 

-

 

Selling and distribution expenses

 

 

(311,446 )

 

 

(83,321 )

 

 

228,125

 

 

 

273.8 %

General and administrative expenses

 

 

(1,017,017 )

 

 

(1,670,829 )

 

 

(653,812 )

 

(39.1)

%

Loss from operations

 

 

(38,526,961 )

 

 

(668,744 )

 

 

(37,858,217 )

 

(5,661.1)

%

Interest income

 

 

23,380

 

 

 

3,622

 

 

 

19,758

 

 

 

545.5 %

Interest expense

 

 

(96,907 )

 

 

(231,704 )

 

 

(134,797 )

 

(58.2)

%

Amortization of debt issuance costs

 

 

-

 

 

 

(177,014 )

 

 

(177,014 )

 

(100.0)

%

Loss from equity method investment

 

 

-

 

 

 

(431,180 )

 

 

(431,180 )

 

(100.0)

%

Other income, net

 

 

1,010,067

 

 

 

1,003,031

 

 

 

7,036

 

 

 

0.7 %

Gain on disposal of subsidiaries

 

 

-

 

 

 

250,331

 

 

 

(250,331 )

 

(100.0)

%

Loss before income taxes

 

 

(37,590,421 )

 

 

(251,658 )

 

 

37,338,763

 

 

 

14,837.1 %

Income tax expenses

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net loss

 

$ (37,590,421 )

 

$ (251,658 )

 

$ 37,338,763

 

 

 

14,837.1 %

 

Revenues

 

Revenue is generated from processing, distributing, and trading dried Shiitake mushrooms, Mu Er (also known as Auricularia heimuer or black ear fungus), other edible fungi, other agricultural products trading business (e.g., tapioca, corn, cotton, and cornstarch), and logistic services.

 

The trading of agriculture products (e.g., corn, and red dates) was mainly based on market opportunity of matching suppliers and customers. Hence, the sales volume may fluctuate according to market demand and supply, and there is no pattern of such agriculture product trading.

 

 
2

 

 

The following table sets forth the breakdown of our revenues for the six months ended March 31, 2026 and 2025, respectively:

 

For the Six Months Ended

March 31,

Variance

2026

%

2025

%

Amount

%

Shiitake

$ 1,854,057 29.0 % $ 6,668,963 41.3 % $ (4,814,906 ) (72.2 )%

Mu Er

1,846,572 28.9 % 5,255,756 32.6 % (3,409,184 ) (64.9 )%

Logistic services

2,694,084 42.1 % 3,407,535 21.1 % (713,451 ) (20.9 )%

Corn

- - 782,946 4.8 % (782,946 ) (100.0 )%

Other edible fungi

- - 29,109 0.2 % (29,109 ) (100.0 )%

Total revenue

$ 6,394,713 100.0 % $ 16,144,309 100.0 % $ (9,749,596 ) (60.4 )%

 

Total revenues for the six months ended March 31, 2026 decreased by $9.7 million, or 60.4%, to approximately $6.4 million from approximately $16.1 million for the same period of the prior fiscal year.

 

Revenue from sales of Shiitake decreased by $4.8 million, or 72.2%, to $1.9 million for the six months ended March 31, 2026 from $6.7 million for the same period of last year. This decline was primarily driven by reduced market demand for shiitake, which led to lower customer order volumes and a corresponding drop in sales quantity.

 

Revenue from sales of Mu Er decreased by $3.4 million, or 64.9%, to $1.8 million for the six months ended March 31, 2026 from $5.3 million for the same period of last year. This decline was primarily driven by reduced market demand for Mu Er, which led to lower customer order volumes and a corresponding drop in sales quantity.

 

Revenue from logistic services decreased by $0.7 million, or 20.9%, to $2.7 million for the six months ended March 31, 2026 from $3.4 million for the same period of last year. Commencing in December 2024, substantially all logistics revenue was generated from the “one-piece shipping service” executed under the December 12, 2024 Overseas Warehouse Distribution Service Agreement with an unrelated third party. Under this arrangement, the Company provides end-to-end overseas warehousing and fulfillment services supported by a rented third-party-developed Warehouse Management System (WMS), which enables core capabilities across inventory governance, order orchestration, settlement reconciliation, and delivery lifecycle tracking. The period-over-period revenue variance is driven principally by diminished market operational activity, which has resulted in contracted customer order flow and a corresponding decline in total logistics throughput.

 

Revenue from sales of corn decreased by $0.8 million, or 100%, to nil for the six months ended March 31, 2026 from $0.8 million for the same period of last year. The decrease was mainly attributable to no such trading of corn for the six months ended March 31, 2026, while there was trading of corn for the same period of last year.

 

Revenue from sales of other edible fungi decreased by $29,109, or 100%, to nil for the six months ended March 31, 2026 from $29,109 for the same period of last year, mainly due to the decreased sales volume arising from reduced market demand for other edible fungi which resulted in a decrease of customer orders.

 

 
3

 

 

Cost of Revenues

 

The following table sets forth the breakdown of the Company’s cost of revenues for the six months ended March 31, 2026 and 2025, respectively:

 

For the Six Months Ended

March 31,

Variance

2026

%

2025

%

Amount

%

Shiitake

$ 1,685,326 22.5 % $ 5,890,949 38.5 % $ (4,205,623 ) (71.4 )%

Mu Er

1,663,822 22.2 % 4,683,022 30.5 % (3,019,200 ) (64.5 )%

Logistic services

4,134,939 55.2 % 3,953,543 25.8 % 181,396 4.6 %

Corn

- - 782,623 5.1 % (782,623 ) (100.0 )%

Other edible fungi

- - 19,598 0.1 % (19,598 ) (100.0 )%

Total

$ 7,484,087 99.9 % $ 15,329,735 100.0 % $ (7,845,648 ) (51.2 )%

 

Cost of revenues decreased by $7.8 million, or 51.2%, to $7.5 million for the six months ended March 31, 2026 from $15.3 million for the same period of last year. As illustrated in the table above, the decrease was mainly attributable to the decrease in sales of shiitake and Mu Er and no trading of corns or other agricultural products, and the decrease was partially offset by the increase of $0.2 million in the cost of revenues associated with logistic services which related to “one piece shipping service” since December 2024 whereby the Company provides overseas warehousing services, final logistics services, and other related value-added services in Chino, California.

 

 
4

 

 

Gross Profit

 

The following table sets forth the breakdown of gross (loss) profit for the six months ended March 31, 2026 and 2025, respectively:

 

 

 

For the Six Months Ended

March 31,

 

 

Variance

 

 

 

2026

 

 

%

 

 

2025

 

 

%

 

 

Amount

 

 

%

 

Shiitake

 

$ 168,731

 

 

 

(15.5 )%

 

$ 778,014

 

 

 

95.5 %

 

$ (609,283 )

 

 

(78.3 )%

Mu Er

 

 

182,750

 

 

 

(16.8 )%

 

 

572,734

 

 

 

70.3 %

 

 

(389,984 )

 

 

(68.1 )%

Logistic services

 

 

(1,440,855 )

 

 

132.3 %

 

 

(546,008 )

 

 

(67.0 )%

 

 

(894,847 )

 

 

(363.9 )%

Corn

 

 

-

 

 

 

-

 

 

 

323

 

 

 

0.0 %

 

 

(323 )

 

 

(100.0 )%

Other edible fungi

 

 

-

 

 

 

-

 

 

 

9,511

 

 

 

1.2 %

 

 

(9,511 )

 

 

(100.0 )%

Total

 

$ (1,089,374 )

 

 

100.0 %

 

$ 814,574

 

 

 

100.0 %

 

$ (1,903,948 )

 

 

(233.7 )%

 

Overall gross profit decreased by $1.9 million, or 233.7%, to a gross loss of $1.1 million for the six months ended March 31, 2026 from a gross profit of $0.8 million for the same period of last year. The decrease in gross profit was mainly attributable to gross loss incurred by logistic services due to gestation period of aforementioned “one piece shipping service” commenced since December 2024, and gross profits of shiitake and Mu Er reduced by $0.6 million and $0.4 million as competitive market reduced gross margins for both shiitake and Mu Er, respectively.

 

(Allowance for) reversal of allowance for credit losses

 

Allowance for credit losses increased by approximately $29.1 million, from a $0.3 million reversal in the prior-year period to a $29.1 million expense in the current period. The increase was mainly attributable to allowance of approximately $31.7 million for advances to suppliers. During the six months ended March 31, 2026, the Company reassessed the recoverability of its advances to suppliers in connection with management’s decision to substantially reduce and exit certain operations in the PRC. Prior to this decision, the Company expected to utilize the advances through future purchases of agricultural products from the relevant suppliers. Following the strategic decision, which was finalized subsequent to the issuance of the Company’s financial statements for the year ended September 30, 2025, the Company no longer expected to utilize a significant portion of these advances through future purchases. Accordingly, the Company evaluated the amounts expected to be recovered from the suppliers and recognized an additional allowance of approximately $31.7 million during the six months ended March 31, 2026 for amounts determined not to be recoverable, as partially offset by reversal of allowance for credit losses of $2.7 million in accounts receivable due to collection of aged accounts receivable.

 

Long-term investment impairment loss

 

Long-term investment impairment loss was approximately $7.0 million for the six months ended March 31, 2026, compared to nil for the same period of 2025. The impairment was primarily attributable to changes in management’s expectations regarding the recoverability of the investment in connection with a significant reduction in the Company’s core business activities in the PRC and management’s strategic decision to substantially reduce and exit certain operations in the PRC. As a result, the Company determined that the decline in value of the investment was other than temporary and recognized an impairment loss during the period.

 

Selling and distribution expenses

 

Selling and distribution expenses increased by $0.2 million, or 273.8%, to $0.3 million for the six months ended March 31, 2026 from $83,321 for the same period of last year. The increase was primarily attributable to the commission and fees incurred for the “one piece shipping service” since December 2024.

 

General and administrative expenses

 

General and administrative expenses decreased by $0.7 million, or 39.1%, to approximately $1.0 million for the six months ended March 31, 2026 from $1.7 million for the same period of last year. The decrease was primarily attributable to the cost cutting initiatives by the Company which reduced the general and administrative expenses.

 

 
5

 

 

Interest expense

 

Interest expense decreased by $0.1 million, or 58.2%, to $0.1 million for the six months ended March 31, 2026 from $0.2 million for the same period of last year. The interest expenses incurred for the six months ended March 31, 2026 were primarily attributable to interest expenses incurred by promissory notes and long-term loans. This reduction is principally driven by the lower outstanding balance of promissory notes, which resulted in a corresponding decrease in the associated interest expense.

 

Amortization of debt issuance costs

 

Amortization of debt issuance costs decreased by $0.2 million, or 100%, to nil for the six months ended March 31, 2026 from $0.2 million for the same period of last year. On July 30, 2024, the Company and Atlas Sciences, LLC (“Atlas”) entered into a note purchase agreement. Pursuant to the agreement, the Company agreed to issue to Atlas an unsecured promissory note in the original principal amount of $5,355,000 for $5,000,000 in gross proceeds.  The resulting debt discount was amortized on a straight-line basis over the contractual term of the promissory note and was fully recognized in fiscal year 2025. Accordingly, no corresponding amortization of debt issuance costs was recorded for the six months ended March 31, 2026.

 

Loss from equity method investment

 

On February 28, 2024, Farmmi International Limited (“Farmmi International” or the “Buyer”), a wholly-owned subsidiary of the Company, entered into an equity transfer agreement with Malong Limited, a Hong Kong company (the “Seller”) to acquire a 45% equity of Ewayforest Group Limited (the “Target”), a Hong Kong company and a wholly owned subsidiary of the Seller. The Target owns 100% of the equity of Lishui Ganglisen Enterprise Management Co., Ltd, a Chinese company, which in turn owns 100% of the equity of Lishui Senbo Forestry Co., Ltd, a Chinese company (“Senbo Forestry”). Senbo Forestry is engaged in forestry management, improvement, planting and product sales. The Target had an appraised value of approximately RMB1.6 billion (approximately $220.2 million) as of December 31, 2024 based on an asset appraisal report issued by an independent third-party appraisal firm.

 

Pursuant to the agreement, Farmmi International would pay a total purchase price of RMB723,324,150 ($99,676,733) for 45% of the Target’s equity (the “Equity”). The parties had agreed that the Buyer would pay $35 million in cash and $35 million in the form of accounts receivable by March 31, 2025, with the remaining purchase price of $29,085,500 to be settled by September 2025. The parties had further agreed the date on which the Seller received the first installment of the purchase price should be deemed the closing date of the transaction. Within one month after receiving the first installment of the purchase price, the Seller should complete the procedures for amending the Target’s articles of association and transferring the Equity. The Target was also required to have a two-member board of directors with one director appointed by each of the Buyer and the Seller. The agreement contains customary representations, warranties and covenants of the Buyer and the Seller, and is subject to certain customary closing conditions. However, due to Senbo Forestry’s inability to obtain a forest ownership certificate for its forest assets, the ownership of the relevant assets could not be confirmed. On September 30, 2025, Farmmi International and the Seller reached an agreement to terminate the original asset/equity acquisition transaction and to refund the consideration Farmmi International had previously paid. As a result, an equity investment loss of $431,180 was recognized for the six months ended March 31, 2025, whereas no such loss was incurred by the Company during the six months ended March 31, 2026.

 

Other income

 

Other income increased by $7,036, or 0.7%, to approximately $1.0 million for the six months ended March 31, 2026 from approximately $1.0 million for the same period of last year. Other income was mainly generated by the Company’s U.S. subsidiaries, which leased three warehouses in earning warehouse sublease rental income. There was no significant fluctuation in sublease rental income for the period concerned.

 

Gain on disposal of subsidiaries

 

On March 31, 2025, an agreement was signed to divest 100% interest in Farmmi Food and Farmmi Supply Chain to a third party for a total cash consideration of RMB20,000 ($2,754). The gain on disposal of these subsidiaries was $0.2 million for the six months ended March 31, 2025.

 

Net loss

 

As a result of the factors described above, net loss was $37.6 million and $0.3 million for the six months ended March 31, 2026 and 2025, respectively.

 

 
6

 

 

Liquidity and Capital Resources

 

We are a holding company incorporated in the Cayman Islands. We may need dividends and other distributions on equity from our PRC and U.S. subsidiaries to satisfy our liquidity requirements. Current PRC regulations permit our PRC subsidiaries to pay dividends to us only out of their accumulated profits, if any, determined in accordance with PRC accounting standards and regulations. In addition, our PRC subsidiaries are required to set aside at least 10% of their respective accumulated profits each year, if any, to fund certain reserve funds until the total amount set aside reaches 50% of their respective registered capital. Our PRC subsidiaries may also allocate a portion of its after-tax profits based on PRC accounting standards to employee welfare and bonus funds at their discretion. These reserves are not distributable as cash dividends.

 

Our ability to distribute dividends largely depends on earnings from our PRC subsidiaries and their ability to pay dividends out of earnings. The Company recorded a net loss of approximately $37.6 million for the six months ended March 31, 2026. The above matters raise substantial doubt about the Company’s ability to continue as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. As of March 31, 2026, the Company had cash balance of approximately $0.2 million.

 

Management plans to address the conditions that raise substantial doubt about the Company’s ability to continue as a going concern through (i) obtaining additional equity or debt financing and (ii) reducing cash used in operating activities. While the Company has successfully raised $8.8 million in gross proceeds through equity financings and reduced the principal balance of the July 2024 promissory note by approximately $0.6 million in the period after March 31, 2026, such changes in the Company’s liquidity condition may not be sufficient to completely remedy the existing going concern risk and cash requirements for its operations. Additionally, the Company may need additional capital in the future to fund its further expansion. If the Company determines that its cash requirements exceed the amount of cash it has on hand at the time, the Company may seek to issue equity or debt securities or obtain credit facilities. The issuance and sale of additional equity would result in further dilution to shareholders of the Company.

 

As of March 31, 2026, we had cash of $0.2 million. In assessing liquidity, management monitors and analyzes our cash on-hand, ability to generate sufficient revenue sources in the future, and operating and capital expenditure commitments.

 

As of March 31, 2026, the Company had working capital of approximately $63.5 million. The Company’s working capital requirements are influenced by the level of operations, revenue generated from products and services, costs and expenses controlled, encashment of accounts receivable.

 

The Company intends to finance future working capital requirements and capital expenditures from cash generated from operating activities and funds raised from financing activities. The Company may, however, require additional cash due to changing business conditions or other future developments, including any investments or acquisitions that the Company may decide to pursue. With the current working capital, the Company believes that the current cash together with cash generated from operating activities and financing activities will not be sufficient to meet the present anticipated working capital requirements and capital expenditures. If existing cash is insufficient to meet requirements, the Company may seek to issue debt or equity securities or obtain additional credit facilities. Financing may be unavailable in the amounts sufficient for the Company’s need or on terms acceptable to the Company, if at all. Issuance of additional equity securities, including convertible debt securities, would dilute earnings per share. The incurrence of debt would divert cash for working capital and capital expenditures to service debt obligations and could result in operating and financial covenants that restrict operations and ability to pay dividends to shareholders. If the Company is unable to obtain additional equity or debt financing as required, the Company’s business and prospects may suffer.

 

Indebtedness. As of March 31, 2026, we have $2.5 million promissory notes. Besides this indebtedness, we did not have any finance leases or purchase commitments, guarantees, or other material contingent liabilities.

 

Off-Balance Sheet Arrangements. We have not entered any financial guarantees or other commitments to guarantee the payment obligations of any third parties. In addition, we have not entered into any derivative contracts that are indexed to our own shares and classified as shareholders’ equity, or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity, or market risk support to such entity. Moreover, we do not have any variable interest in any unconsolidated entity that we provide financing, liquidity, market risk, or credit support to or engage in hedging or research and development services with us.

 

Capital Resources. The primary drivers and material factors impacting our liquidity and capital resources include our ability to generate sufficient cash flows from our operations and renew commercial bank loans, as well as proceeds from equity and debt financing, to ensure our future growth and expansion plans.

 

 
7

 

 

Working Capital. Total working capital as of March 31, 2026 amounted to $63.5 million, compared to $83.2 million as of September 30, 2025.

 

Capital Needs. Our capital needs include our daily working capital needs and capital needs to finance the development of our business. We have established effective collection procedures of our accounts receivable and have been able to realize or receive the refund of the advances to suppliers in the past. The Company intends to address its liquidity needs through cash generated from operations and additional debt or equity financing. We may raise additional capital through public offerings or private placements to finance our business development and to consummate any merger or acquisition, if necessary. However, there can be no assurance that such financings or acquisition opportunities will be available on acceptable terms, or at all.

 

Cash flows

 

The following table provides detailed information about our net cash flows for the six months ended March 31, 2026 and 2025:

 

 

 

For the Six Months Ended

March 31,

 

 

 

2026

 

 

2025

 

Net cash (used in) provided by operating activities

 

$ (1,280,305 )

 

$ 14,569,967

 

Net cash used in investing activities

 

 

(3,016,796 )

 

 

(15,035,909 )

Net cash provided by financing activities

 

 

3,741,228

 

 

 

875,208

 

Effect of exchange rate changes on cash

 

 

1,027

 

 

 

(5,452 )

Net (decrease) increase in cash

 

 

(554,846 )

 

 

403,814

 

Cash and restricted cash, beginning of period

 

 

804,098

 

 

 

486,522

 

Cash and restricted cash, end of period

 

$ 249,252

 

 

$ 890,336

 

 

Operating Activities

 

Net cash used in operating activities was $1.3 million for the six months ended March 31, 2026, as compared to net cash provided by operating activities of $14.6 million for the six months ended March 31, 2025, which mainly consisted of (i) net loss of $37.6 million; (ii) an increase of $3.9 million in accounts receivable due to sales; and (iii) a decrease in allowance for accounts receivable of $2.7 million due to collection from aged accounts receivable; this was partially offset by (i) a net decrease of $8.8 million in advances to suppliers due to allowance for credit losses for certain aged suppliers; and a decrease of $23.9 million in note receivable due to collection.

 

Investing Activities

 

For the six months ended March 31, 2026, net cash used in investing activities amounted to $3.0 million as compared to net cash used in investing activities of $15.0 million for the same period of 2025, which mainly consisted of loan of $3.8 million to a third party and purchase of $0.4 million in property and equipment, as partially offset by repayment of $1.2 million in loan to a third party.

 

Financing Activities

 

Net cash provided by financing activities amounted to $3.7 million for the six months ended March 31, 2026, as compared to net cash provided by financing activities of $0.9 million for the same period in 2025, which mainly consisted of proceeds of $3.6 million from advances from related parties and proceeds of $2.0 million from issuance of ordinary shares for warrants exercised, as partially offset by repayment of $1.8 million to a third-party loan.

 

Commitments and Contractual Obligations

 

The following table presents the Company’s material contractual obligations as of March 31, 2026:

 

 

 

 

 

Less than

 

 

1-2

 

 

3-5

 

 

More than

 

Contractual obligations

 

Total

 

 

1 year

 

 

years

 

 

years

 

 

5 years

 

Promissory notes

 

$ 2,519,134

 

 

$ 2,519,134

 

 

 

-

 

 

 

-

 

 

 

-

 

Operating lease obligations

 

 

18,920,505

 

 

 

5,391,086

 

 

 

7,122,876

 

 

 

5,905,267

 

 

 

501,276

 

Total

 

$ 21,439,639

 

 

$ 7,910,220

 

 

$ 7,122,876

 

 

$ 5,905,267

 

 

$ 501,276

 

 

 
8